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ABSTRACT 
 
MYO1C BINDS TO PIP2 WITH HIGH AFFINITY THROUGH A PUTATIVE  
PH DOMAIN 
 
David Hokanson 
 
Dr. E. Michael Ostap 
 
Myo1c is a member of the myosin superfamily that links the dynamic actin cytoskeleton to the 
membrane, and plays roles in mechano-signal transduction and membrane trafficking.  We located and 
characterized two distinct membrane binding sites within the regulatory and tail domains of this myosin.  
We found that the tail domain binds tightly and specifically to PIP2 in a non-cooperative manner.  It binds 
with slightly higher affinity to Ins(1,4,5)P3 as well as other inositol phosphates which may act as 
inhibitors to membrane binding in the cell.  By sequence and secondary structure analysis, we identified 
this phosphatidylinositol binding site in the tail to be a putative pleckstrin homology (PH) domain.  Point 
mutations of residues known to be essential for phosphatidylinositol binding in previously characterized 
PH domains inhibit myo1c binding to PIP2 in vitro and eradicate correct localization and membrane 
binding in vivo.  The extended sequence of this binding site is conserved within many other myosin-Is 
across species, suggesting they also contain a putative PH domain. We also characterized a previously 
identified membrane binding site within the IQ motifs in the regulatory domain.  This region is not 
phosphatidylinositol specific, but binds anionic phospholipids in a Ca
2+
 dependent manner; nevertheless, 
this site is not essential for in vivo membrane binding.  As a result, we have determined that myo1c 
contains two lipid binding sites, a polybasic region that binds to high levels of PS in a Ca
2+
 dependent 
manner and a putative PH domain that binds tightly and specifically to phosphatidylinositols. 
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Preface 
When I was looking for a graduate school, while finishing my undergrad 
degrees at Ohio University, I didn’t know what to expect.  I was in complete disbelief 
after I took my GRE that schools were actually going to pay ME to go to school instead 
of the other way around.  Initially, I selected just two schools to apply to based on the 
protein folding research that was being done by the faculty, and avoiding any of the 
pompous Ivy-league schools.  I was fortunately unaware at the time that the University 
of Pennsylvania was, in fact, an Ivy-league school, or I would never have applied.  My 
girlfriend at the time hid this from me, and for that I am grateful.  When I discovered 
the truth a fortnight before my interview, I almost cancelled, but instead I reserved my 
prejudice and came anyway.  I was shocked at how collaborative and non-cutthroat 
Penn was.  It seemed to have all the success and prestige I envisioned an Ivy-league 
school to have, but was also laid back and friendly.  My interview went well and I knew 
this was where I would end up for the next five to seven years of my life. 
 Mercifully, it has only taken me five years to finish my thesis; although, I have 
never been in a hurry to leave Philly or Penn.  The best decision I could have made was 
working for Dr. Mike Ostap.  I was Mike’s first graduate student, yet it seemed as 
though he had mentored hundreds before me.  I truly believe that much of my happiness 
here at Penn is due to having a great mentor and lab environment.  For anyone that has 
watched the NBC show, “Scrubs”, Mike is my Dr. Cox.  He picks on me constantly and 
never quite gives me that pat on the back I yearn for, but inspires me to work even 
harder to get it.  To me, Mike is much more than just a brilliant boss who has all the 
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answers and is rarely wrong, he is a truly inspiring human being.  I can’t think of a 
better man to look up to professionally. 
 There are many people at Penn that I owe some part of my sanity to, including 
the faculty on my committee and in the PMI, fellow graduate students, and Ruth and 
Angie in the department offices.  After my prelim, I was worried about picking such 
well-established faculty to serve on my thesis committee for fear that they would make 
my life hell.  However, with each committee meeting I learned that their vast 
knowledge and expertise in my field were indispensable and made my work more 
forthright, not more grueling.  Also, I’ve made some great friends here and without 
them, finishing graduate school would have been a much more menacing feat.  Thank 
you fellow BMB students. 
 The Ostap lab is smaller than most labs, and I think that was beneficial to me as 
a beginning graduate student.  I would like to thank current and past members of the 
lab, in particular, Nanyung, Tianming, Joe, and Jennine.  Nanyung was a postdoc when 
I started in the lab and played a hand in training me to do many of the things I now take 
for granted (I just wish some of her cloning magic wore off on me).  Tianming, what 
isn’t there to say about Tianming.  He is an invaluable member of the lab to me and 
everyone else.  Never complaining, always willing to help, and an absolute master of 
what he does everyday.  Thank you Tianming for constantly keeping the lab stocked 
with protein and helping in every way you can.  Joe has given me the much needed 
comic relief I’ve needed to get through the frustrating days over the years.  You’ve 
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always been there to ask the stupid questions I’m too embarrassed to ask Mike.  Jennine 
has been a very welcomed new addition to the lab.  I’m thrilled there is someone to take 
over my project at least in part when I depart.  I have enjoyed trying to play the role of a 
mentor and it is humanitarian of you to always laugh at my jokes. 
 And lastly I would like to thank my family and extended family, my friends.  
Dad, you always said you would buy me a car if I followed in your footsteps and 
graduated from med school.  Well, I’m graduating from the University of Pennsylvania 
School of Medicine, it’s a technicality I know, but I’ll take what I can get.  Thank you 
for always believing in me and supporting me through undergrad and the rough times 
since.  Liz, I’m so glad we are still as close as ever.  Your support at the beginning and 
now has always meant so much to me.  I am ecstatic that you are ecstatic for me.  Oh 
and I guess thanks for the help with Illustrator too.  Bryan, you’ve always been a great 
friend here at Penn: may we continue to brew great beer and times together for many 
years.  And of course a big thank you to my beautiful girlfriend Sarah (Dorkface).  I 
know I’m probably more difficult than you’ve ever imagined, but I hope it has been 
worth it for you because it certainly has been for me.  Your English major background 
has been a big help with the editing, but it doesn’t come close to the mental and 
emotional clutch you have been…when I let you.  Thank you to everyone, I love you 
all.  “All right, brain, I don’t like you and you don’t like me, so let’s just do this and I’ll 
get back to killing you with beer.” Homer Simpson. 
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1 Introduction 
1.1 Objective    
The myosin super-family is very diverse and expands well beyond the typical 
myosin II stereotype found in muscle.  Most characterized myosins are able to bind 
actin filaments through their motor domain, possess ATPase activity, and are able to 
generate force.  Humans express 40 different myosin genes that differ in the kinetics of 
their motor domains, and the cargo binding of their tail domains.  Eight of these 
myosins are class-I isoforms.  It has been known since 1989 that myosin-I isoforms 
associate with anionic lipids, yet the specificity and lipid binding site(s) were not 
known.  The overall purpose of this dissertation was to characterize the interaction of a 
myosin-I motor with the plasma membrane.  The focus of this thesis is myo1c, a single 
headed, membrane associated isoform that is found in most eukaryotic cells and is 
involved in membrane dynamics, cytoskeletal structure, and mechano-signal 
transduction.  Little was known of the mechanism by which myo1c bound to the 
membrane or what kinds of forces it could generate once anchored to the fluid bilayer.  
Knowing the specificity and mechanism of how a myosin-I interacts with lipids was 
essential for understanding the possible functions of an actin-based motor bound to the 
plasma membrane.  Therefore, my aim was to characterize the protein-lipid interactions 
in much greater detail. 
 
1.2 Summary 
Myo1c is a member of the myosin superfamily that links the dynamic actin 
cytoskeleton to the membrane, and plays roles in mechano-signal transduction and 
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membrane trafficking.  We located and characterized two distinct membrane binding 
sites within the regulatory and tail domains of this myosin.  We found that the tail 
domain binds tightly and specifically to PIP2 in a non-cooperative manner.  It binds 
with slightly higher affinity to Ins(1,4,5)P3 as well as other inositol phosphates which 
may act as inhibitors to membrane binding in the cell.  By sequence and secondary 
structure analysis, we identified this phosphatidylinositol binding site in the tail to be a 
putative pleckstrin homology (PH) domain.  Point mutations of residues known to be 
essential for phosphatidylinositol binding in previously characterized PH domains 
inhibit myo1c binding to PIP2 in vitro and eradicate correct localization and membrane 
binding in vivo.  The extended sequence of this binding site is conserved within many 
other myosin-Is across species, suggesting they also contain a putative PH domain. We 
also characterized a previously identified membrane binding site within the IQ motifs in 
the regulatory domain.  This region is not phosphatidylinositol specific, but binds 
anionic phospholipids in a Ca
2+
 dependent manner; nevertheless, this site is not essential 
for in vivo membrane binding.  As a result, we have determined that myo1c contains 
two lipid binding sites, a polybasic region that binds to high levels of PS in a Ca
2+
 
dependent manner and a putative PH domain that binds tightly and specifically to 
phosphatidylinositols. 
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1.3 Background 
1.3.1 Myosin   
Myosins are molecular motors that convert the chemical energy from ATP to a 
mechanical force along actin filaments in the cell.  Conventional myosin, myosin-II, 
was the first molecular motor to be discovered and has been studied for many decades 
due to its fundamental role in muscle contraction.  Myosin-II is a two-headed molecule 
that oligomerizes into bipolar filaments, which slide relative to actin filaments to create 
a contraction in muscle cells.  In 1973, the first unconventional myosin, Acanthamoeba 
myosin-I, was discovered (Pollard and Korn 1973).  There are now 24 classes of 
myosins identified (Figure 1) (Foth, Goedecke et al. 2006) with humans expressing 40 
different myosin genes.  Mutations in myosin genes lead to a variety of diseases 
including myopathies, hearing loss, and blindness.  Myosins are involved in a large 
number of cellular processes, such as muscle contraction, cell motility, cytokinesis, 
phagocytosis, growth cone extension, maintenance of cell shape, mechano-signal 
transduction, endocytosis, exocytosis, and organelle/particle trafficking. 
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Figure 1 Myosin Family Tree 
 
Figure 1: The most recent phylogenetic tree of the myosin super family from (Foth, 
Goedecke et al. 2006).  It was created from a representative distance matrix-based 
phylogeny (PROTDIST_NEIGHBOR) of myosin head domains.  Listed are the 24 
classes of myosin motors that have been identified.  Note that the largest family 
consists of members of the myosin-I family. 
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 1.3.1.1 Myosin Domain Structure 
All characterized members of the myosin super family contain a head, neck and 
tail domain (Figure 2).  The head domain is an 80 kDa catalytic motor, which binds to 
actin and hydrolyzes ATP to induce a powerstroke.  The degree of conservation varies 
among families and isoforms, and results in observed enzymatic differences in the 
ATPase cycle of the myosin.  The neck domain is an extended α-helical light chain-
binding region consisting of one or more IQ motifs, which have a 23 residue consensus 
sequence IQXXXRGXXXRK.  These IQ motifs bind to light chains, such as 
calmodulin (CaM), or other EF-hand proteins that stiffen the α-helix and regulate the 
myosin in a Ca
2+
 dependent manner (Zhu, Beckingham et al. 1998).  The neck domain 
serves as a lever arm that transduces small conformational changes in the motor domain 
to larger displacements. The tail domain is varied among the different myosin isoforms 
and in many cases determines the localization and function of the myosin.  The tail 
domain exhibits class-specific properties such as filament forming, dimerizing, cargo 
binding, or kinase activity (Mooseker and Cheney 1995).  This thesis will focus on the 
regulatory and tail domain of myo1c, a class I myosin. 
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Figure 2 Myosin Structure 
  Figure 2: Model of myosin-II bound to actin from (Holmes, Schroder et al. 2004).  
Crystal structure of myosin–II bound to a modeled actin filament, which is shown 
on the left.  Myosin-II is shown in A) pre-powerstroke, and B) post-powerstroke 
conformations.   The 80 kDa head domain is shown in red, cyan, yellow and green, 
and the regulatory domain is shown in blue with light chains (purple and yellow) 
bound.  The tail domain is not present in this structure. 
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1.3.1.2 Myosin ATPase Cycle 
Myosin motors bind and hydrolyze ATP to convert chemical energy to a 
mechanical force used to translocate actin filaments (Figure 3).  Myosin in a nucleotide-
free state remains tightly bound to actin in what is referred to as the rigor state.  Upon 
ATP binding, myosin enters a weak actin binding state and dissociates from the 
filament. ATP is hydrolyzed and the myosin lever arm is cocked into a pre-powerstroke 
conformation.  Upon binding to actin, phosphate (Pi) is released and the lever arm is 
moved forward during the powerstroke as myosin enters the strong binding state.  ADP 
is released, which results in a second sub-step for some isoforms, and the myosin 
returns to the rigor state.  A new ATP molecule is now able to bind to the myosin motor 
to repeat the cycle.  Although all myosins follow this cycle, the kinetics and regulation 
of these steps can differ greatly between myosin families and even isoforms.  The rate 
limiting step for myosin-I motors is Pi release, which means that myosin-Is most often 
exist in the weakly bound state.  However, they have been proposed to enter a state of 
isometric contraction that prevents ADP release under stall forces, which may increase 
their lifetime bound to actin (Batters, Arthur et al. 2004).  This proposed function of 
myosin-Is to act as a tension sensor will be further discussed throughout. 
8 
 
 
 
Figure 3 Myosin ATPase cycle 
  
Figure 3:  The ATPase cycle of a myosin motor is shown as A) a 
cartoon model, and B) a kinetic scheme  from (Murphy, Rock et al. 
2001).  Strong actin bound states are shown in red, whereas weak 
actin bound states are shown in blue.  Note, the powerstroke is 
depicted as occurring after Pi release; however, this point remains to 
be settled (Dantzig, Goldman et al. 1992; Takagi, Homsher et al. 
2006). 
9 
 
 
1.3.1.3 Ca2+ Regulation of Light Chains 
 Most characterized myosins contain one or more IQ motifs in their regulatory 
domain that bind to EF-containing light chains in a Ca
2+
 dependent manner.  These light 
chains are thought to structurally stabilize the regulatory domain, which is a long α-
helix that would be flaccid without light chains bound.  In the case of many myosins, 
this light chain is CaM, which contains two lobes, each containing two EF hand motifs 
that can each bind to two Ca
2+
 ions (Figure 4).  CaM undergoes a conformational 
change when Ca
2+
 binds, which in most cases lowers the affinity of CaM for the IQ 
motifs, and can even lead to dissociation of the CaM.  For myosin-Is, this is proposed to 
reveal positively charged residues within the IQ motifs, which can then bind through 
electrostatic interactions to the negatively charged phospholipids in the plasma 
membrane (Swanljung-Collins and Collins 1992; Tang, Lin et al. 2002; Hirono, Denis 
et al. 2004); although, this property has not been shown to be physiologically relevant. 
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Figure 4 CaM Bound to IQ Peptide 
  Figure 4: Structure of two apo-CaM light chains bound to a 
portion of the regulatory domain consisting of 6 adjacent IQ 
motives of myosin-V.  Two CaM light chains, cyan and green, are 
shown bound a section of the regulatory domain, magenta, 
containing two adjacent IQ motifs (PDB 2IX7). 
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1.3.2 Myosin-I 
Myosin-Is comprise the largest unconventional myosin family in humans (Berg, 
Powell et al. 2001) where they function in membrane dynamics, cell structure, 
endocytosis, and mechanical signal transduction (Ruppert, Godel et al. 1995; Tang and 
Ostap 2001; Bose, Guilherme et al. 2002; Holt, Gillespie et al. 2002; Tyska, Mackey et 
al. 2005; Sokac, Schietroma et al. 2006).  They are single-headed myosins that do not 
dimerize or form filaments.  The IQ motifs in the regulatory domain of all vertebrate 
myosin-Is each bind to a CaM.  The tail domains of myosin-Is are highly basic and bind 
to anionic lipids in the plasma membrane.  Myosin-Is can be further divided into two 
sub-classes, the short-tail and long-tail isoforms.  The long-tail isoforms have two 
additional protein:protein interaction domains, a src homology 3 (SH3) and a glycine-
proline-rich domain.  Vertebrates express six short-tail myosin-Is (myo1a, myo1b, 
myo1c, myo1d, myo1g) and two long-tail isoforms (myo1e, myo1f) (Berg, Powell et al. 
2001). 
 
1.3.2.1 Localization of Myosin-I 
Subcellular fractionations of vertebrate cells show that a large percentage of 
myosin-I is associated with the membrane and the cytoskeletal fractions (Ruppert, 
Godel et al. 1995; Bose, Guilherme et al. 2002; Cho, Kim et al. 2005), and 
immunofluorescence and live cell microscopy suggest that myosin-I is dynamically 
localized to the cell membrane.  Thus, a key property of myosin-I isoforms appears to 
12 
 
 
be their ability to bind in a regulated manner to cellular membranes (Coluccio 1997; 
Tang and Ostap 2001). 
 
1.3.2.2 History of Myosin-I Membrane Association 
The association of myosin-I with anionic lipids has been studied since the late 
1980s.  In 1989, Pollard showed that Acanthamoeba myosin-I bound to both extracted 
membranes and to vesicles of pure lipids (Adams and Pollard 1989) and Korn found 
that Acanthamoeba myosin-I localized to the plasma membrane (Miyata, Bowers et al. 
1989).  A year later, Mooseker discovered that a vertebrate myosin-I, myo1a, bound to 
anionic lipid vesicles through its tail domain (Hayden, Wolenski et al. 1990), which 
Pollard also found to be true of Acanthamoeba myosin-I (Doberstein and Pollard 1992).  
Since then, many laboratories have shown through in vivo experiments that myosin-I 
isoforms associate with anionic phospholipids (Hirono, Denis et al. 2004; Huang, 
Lifshitz et al. 2004).  Kinetic studies of myo1c showed that association rates with acidic 
large unilamellar vesicles (LUVs) were diffusion limited, whereas the dissociation rates 
depended on the ratio of PS to myo1c-tail and was slower than the myo1c ATPase rate 
(Tang, Lin et al. 2002).   
Since myosin-Is are able to bind to both the cell membrane and actin, this leads 
to many possible mechanical functions. A dynamic link between the actin cytoskeleton 
and membrane can be formed. This could deform the membrane, form barriers, or form 
micro-domains around proteins in the membrane with the cytoskeleton acting much like 
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a fence around cattle, supplying support and rigidity. Myosin-Is could also bind to 
endocytic vesicles and transport them along an actin track, or aid in retrograde flow. 
One of the molecular roles that has become more characterized in recent years is the 
role of myo1c as a mechanical signal transducer in hair cells (Batters, et al. 2004).  
Although there are many hypotheses in the scientific community, there is still 
little evidence as to what myosin-Is can functionally do while bound to the membrane.  
Therefore, the goal of this thesis was to characterize the interactions of a particular 
myosin-I isoform, myo1c, with the plasma membrane, thus leading to a better 
understanding of its molecular roles as a link between the plasma membrane and the 
cytoskeleton. 
 
1.3.3 Myo1c   
Myo1c has been shown to play roles in lamellipodial retraction, endosomal 
processing, glucose transportation, and mechanical signal transduction. It is widely 
expressed in vertebrate cell types and is largely localized to the plasma membrane and 
cytoskeleton (Ruppert, Godel et al. 1995; Bose, Guilherme et al. 2002; Cho, Kim et al. 
2005). This is especially true at specialized dynamic membrane structures such as 
lamellipodia, microvilli, endocytic structures and inner-ear hair cell stereocilia.  Myo1c 
has also been shown to be enriched in micro domains through proteonimics analysis 
(Saeki, Miura et al. 2003).  However, the functions and regulation of myo1c while 
bound to the plasma membrane are still unknown. 
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1.3.3.1 Possible Functions of Myo1c 
Myo1c being able to bind to both the cell membrane and actin leads to many 
possible mechanical functions.  These functions include tethering the cytoskeleton to 
the membrane, translocating actin in the plane of the membrane, deforming or 
rearranging membrane structures, and acting as a tension sensor.  Although many of the 
biological roles of myo1c are poorly understood, the one role that has become better 
characterized in recent years is the role of myo1c as a mechanical signal transducer in 
hair cells of the inner ear.   
 
1.3.3.2 Myo1c Catalytic Activity 
In order to hypothesize about the possible functions of myo1c while bound to 
the membrane, it is important to first review its biochemical properties.  Myo1c 
hydrolyzes ATP at a rate of 0.1 – 1 s-1 and has a low duty ratio of 0.05 under no load 
(Gillespie, Gillespie et al. 1999).  This means that myosin will be in a strong actin 
binding state only 5% of the time.  Actin activates the ATPase rate by 2 – 10 fold, and 
the actin motility rate has been measured at 100 nm/s (Batters, Arthur et al. 2004).  Ca
2+
 
appears to affect the motility of myo1c by altering its mechanical activity; moreover, 
some laboratories have found that Ca
2+
 increases actin activated ATPase activity 
(Barylko, Wagner et al. 1992; Batters, Arthur et al. 2004).  These effects are most likely 
15 
 
 
due to Ca
2+
 binding to and changing the conformation of CaM light chains bound to the 
IQ motifs in the regulatory domain.    
The powerstroke of myo1c seems to occur in two phases.  The first substep of 
~3 nm correlates with the release of Pi, whereas the second substep of ~1 nm 
corresponds to ADP release (Batters, Arthur et al. 2004).  This is supported by electron 
microscopy data showing a large difference in the position of the neck domain between 
ADP-bound and nucleotide free states (Batters, Arthur et al. 2004).  The kinetics of 
myo1c seem to be load dependent (Batters, Arthur et al. 2004).  Since nucleotide release 
and mechanical states are coupled, one explanation for the motor domain being unable 
to release ADP is myo1c arrest after the first substep, staying strongly bound to ADP 
and maintaining tension.  This would cause the myo1c to remain bound in an isometric 
contraction until either the load is released and it is able to proceed through its catalytic 
cycle, or the load increases and myo1c is forced back into a ADP.Pi-like state in which 
it will detach from actin (Batters, Arthur et al. 2004).  However, the role of myo1c as a 
tension sensor still needs to be demonstrated. 
1.3.4 Biological Roles  
 Myo1c has been implicated through biochemical and cell biological techniques 
to be involved in many different cellular processes.  Many laboratories have shown the 
importance of myo1c function at areas in the cell where the cytoskeleton and membrane 
interact.  However, aside from its role as a mechano-signal transducer in hair cells, no 
precise functional data has been demonstrated for myo1c at the plasma membrane.  
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Characterizing how myo1c interacts with the membrane will give insight to its role in 
the following biological processes. 
1.3.4.1 Compensatory Endocytosis 
Egg activation in Xenopus and several other vertebrates is induced upon 
fertilization by an increase in intracellular Ca
2+
.  This initiates several events, one of 
which is cortical granule exocytosis which is required to block polysperm.  Cortical 
granule containing vesicles lie just beneath the plasma membrane until fertilization.  
Upon activation, they fuse with the membrane and exocytosis commences.  To prevent 
the membrane from growing due to the fusion of cortical granule vesicles, 
compensatory endocytosis takes place just after vesicle fusion.  This process involves 
an actin coat forming around the fused vesicles and compressing it to retrieve the 
vesicle (Sokac, Schietroma et al. 2006). 
Myo1c is upregulated by polyadenylation during meiotic maturation in Xenopus 
eggs.  Upon fertilization, myo1c is recruited to the cortical granule containing vesicle 
preceding actin coat assembly.  Inhibition of myo1c leads to an uncoupling of the actin 
coats from the exocytosing cortical granules, resulting in failure of compensatory 
endocytosis.  There is also an increase in polymerization of actin at the membrane 
throughout the cell.  These findings suggest that myo1c couples the barbed ends of actin 
to the membrane, mediating force production from the polymerizing actin during 
compensatory endocytosis, rather than directly producing force through a powerstroke 
(Sokac, Schietroma et al. 2006).  This requires a specific localization of myo1c to sites 
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of endocytosis as well as a strong link to the plasma membrane to support the actin coat 
and forces of polymerization. 
1.3.4.2 Glucose Exocytosis 
Insulin stimulates the uptake of glucose in muscle and adipocytes by inducing 
the translocation and exocytosis of vesicles containing the glucose transporter protein, 
GLUT4.  This process is required for maintaining normal blood glucose levels.  GLUT4 
translocation requires the actin cytoskeleton.  Rapid and directed movement along 
filaments implicates the involvement of myosin motors, most likely myosin-V (Bose, 
Guilherme et al. 2002).  Phosphatidylinositol-4,5-bisphosphate (PIP2) has also been 
shown to stimulate the glucose transport activity of GLUT4 at the plasma membrane 
(Funaki, DiFransico et al. 2006).  These results suggest that PIP2 acts as a second 
messenger to activate release of GLUT4 through the remodeling of the actin 
cytoskeleton. 
Cells lacking myo1c have a reduced glucose uptake (Bose, Guilherme et al. 
2002).  Over-expression reverses the effect of inhibiting phosphoinositol-3 kinase 
(PI3K), which inhibits GLUT4-containing vesicles and causes them to accumulate right 
below the plasma membrane.  Over-expression also induced membrane ruffling in 
adipocytes which is normally induced by insulin.  GLUT4-containing vesicles have 
been shown to colocalize with myo1c only at the membrane, suggesting that myo1c is 
not involved in translocating vesicles to the membrane, but rather in anchoring them to 
the membrane, fusing them to the membrane, or exocytosis (Bose, Guilherme et al. 
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2002).  Glucose exocytosis clearly requires both PIP2 and myo1c to be present at the 
membrane for proper function. 
 
1.3.4.3 Neuronal Growth Cone Extension 
Neurons extend growth cones from the tips of growing axons to form a precise 
pattern in the nervous system.  They have the ability to maneuver through the 
developing nervous system which is enabled by both actin and microtubule-based 
mechanisms.  Protrusion of the lamellipodia and filopodia at the cell periphery is known 
to be actin-based.  Several myosin motors have been implicated in this process (Wang, 
Wolenski et al. 1996; Wylie, Wu et al. 1998).  Inhibition of myosin-V causes retraction 
of filopodia, whereas inhibition of myosin-II causes reduction in the size of the 
lamellipodia.   
Inactivation of myo1c in chick dorsal root ganglion results in lamellipodial 
extension by actin polymerization (Diefenbach, Latham et al. 2002).  When this 
rearward movement of actin is inhibited, the lamellipodia extends forward unchecked.  
Using chromophore assisted laser inactivation, areas of the lamellipodia where myo1c 
was inactivated would polymerize and extend, causing the neuron to steer in that 
direction (Wang, Liu et al. 2003).  This suggests that myo1c has an effect on actin 
polymerization, or possibly acts to translocate actin filaments rearward.  The 
localization and regulation of myo1c at areas of lamellipodial extension remain unclear. 
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1.3.4.4 Hair Cells 
The most knowledge on a molecular role of myo1c is its role in the stereocilia of 
hair cells as a mechano-sensing transducer.  Hair cells contain bundles of 30 – 300 
actin–filled stereocilia arranged in a tiered arrangement (Figure 5).  Auditory or 
vestibular stimuli, caused by sound or head movements, cause the individual stereocilia 
to move with respect to one another, which results in the opening and closing of 
transduction channels.  When the channels open, cations, K
+
 and Ca
2+
, rush into the 
stereocilia, which depolarizes the cell and causes a neurotransmitter to be released.  The 
channels then close causing the cell to hyper-polarize and cease the release of the 
neurotransmitter (Gillespie 2004).  The channels are opened by tension placed on them 
by an extracellular tip link composed of a filament of cadherin 23 that is connected to 
the tip of an adjacent stereocilia (Siemens, Lillo et al. 2004).   
Hair cells are able to adapt after being initially displaced to retain the same 
intrinsic sensitivity but operate over a higher range of movements.  This suggested that 
there was a change in the mechanical arrangement within the bundles during adaptation.  
For this to occur, the tip link from one bundle must be able to slide down the 
stereocilium of a neighboring stereocilium to reduce the tension felt by the channel and 
allow it to close.  During periods of no simulation, the channel would have to relocate 
back to its original position to restore tension.  This model seemed like a perfect fit for 
myosin-I (Howard and Hudspeth 1987).  Two forms of adaptation have been described 
to occur in hair cells concurrently under distinct mechanisms.  A fast adaptation of a 
few milliseconds for channel closing suggests that Ca
2+
 entering through the channel 
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signals them to shut.  A slow adaptation of 20 ms is thought to be myosin-I based (Holt, 
Gillespie et al. 2002). 
In the hair cells of developing mice, although stereocilia have formed, no 
sensory activity is present until embryonic day 16.  This correlates precisely with the 
formation of tip links and the expression of myo1c (Geleoc and Holt 2003). Three 
components have been found to be essential for adaptation and transduction in hair 
cells, PIP2, cadherin 23, and myo1c (Hirono, Denis et al. 2004; Siemens, Lillo et al. 
2004).  Myo1c has been shown to bind to both cadherin 23 and PIP2 (Phillips, Tong et 
al. 2006).  These interactions allow myo1c to link the transduction apparatus to the 
bundled actin filaments.  Under resting conditions, stereocilia are upright with resting 
tension from the tip links on the transduction channels.  Myo1c bound to actin and the 
transduction complex remains in an isometric contraction, keeping the channel closed.  
When stereocilia move in relation to each other, tension is produced and the tip link 
pulls open the transduction channel as myo1c is forced into an ADP.Pi-like state, 
releases from actin, and slides down the actin bundle.  During the adaptation discussed 
above, myo1c motors, now at the beginning of their catalytic cycle, rebind and climb 
the actin bundle under zero load until tension is restored, thus closing the channel 
(Batters, Arthur et al. 2004). Therefore, myo1c is responsible for allowing the channels 
to open under tension, and then closing them by restoring tension (Gillespie 2004).  
From data showing that the tip link complex can withstand up to 80 pN of force before 
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breaking, it has been estimated that up to 50 myosin motors are required per tip link 
(Hudspeth and Gillespie 1994). 
 
Figure 5 Hair cell 
  
Figure 5: Figure is from (Hirono, Denis et al. 2004).  
Immunogold electron microscopy of hair cell in intact 
saccular epithelium using a monoclonal antibody for PIP2, 
2C11, without subtilisin treatment and with fixative-saline 
permeabilization. Scale bar, 500 nm. 
22 
 
 
1.3.5 Myo1c Binding Partners 
The tail domains of myosin are generally known as the cargo binding domains.  
Many efforts have been made to identify proteins that bind to the tail domain of myo1c 
with little success.  Proteins that bind to the regulatory or tail domain of myo1c could be 
important for its sub-cellular localization and non-redundant functions from other 
myosin-I isoforms.  Binding partners could incorporate myo1c into larger protein 
complexes needed to form at the plasma membrane, or could require myo1c for proper 
positioning at the membrane.  They could also regulate lipid binding or affect the 
kinetics of membrane association or dissociation.  To date, only three proteins have 
been found: cadherin 23, NEMO, and PHR1.   
 
1.3.5.1 Cadherin 23 
Cadherin 23 is a component of the tip link complex in hair cells.  The 
cytoplasmic domain of cadherin 23 was shown to colocalize and immunoprecipate with 
myo1c when coexpressed in HEK cells (Siemens, Lillo et al. 2004).  This interaction 
functions to link the adaptive motor to the transduction channel in stereocilia.  More on 
this function will be discussed later. 
 
1.3.5.2 NEMO 
Nuclear factor κB essential modulator (NEMO) is a subunit of the IκB kinase 
complex which attenuates insulin action by phosphorylating the insulin receptor 
substrate.  NEMO was found to accumulate at membrane ruffles preceding an 
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interaction with the insulin receptor substrate.  Location of NEMO is dependent on 
insulin, actin and myo1c.  Over-expression of myo1c enhanced the interaction between 
NEMO and insulin receptor substrate, while expression of a dominate negative tail 
domain of myo1c inhibited insulin receptor substrate phosphorylation.  NEMO and 
myo1c were shown to interact through both endogenous and recombinant 
immunoprecipation from cell extracts (Nakamori, Emoto et al. 2006).  It is thought that 
myo1c helps localize NEMO at the plasma membrane so that it can form a complex to 
the insulin receptor in order to pacify insulin action through phosphorylation. 
 
1.3.5.2 PHR1  
PHR1 is an integral membrane protein found in photoreceptor cells, olfactory 
receptor neurons, and hair cells.  It has four different splice isoforms that can be 
expressed, and contains a PH domain that lacks the signature motif containing basic 
residues required for phosphatidylinositol binding.  PHR1 interacts with the tail 
domains of myo1c and myoVIIa through this PH domain as evidenced by 
immunoprecipitation and a yeast two hybrid interaction (myo1c only) (Etournay, El-
Amraoui et al. 2005).  Although its role in hair cells is unclear, it has potential functions 
in post golgi protein trafficking and possibly the mechano-transduction slow adaptation 
process through its interaction with myo1c. 
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1.3.6 The Plasma Membrane 
To characterize the interaction of myo1c with the membrane, it is important to 
consider the role of different lipids that make up the inner leaflet.  The plasma 
membrane in most cells is made up of transmembrane proteins and a variety of 
phospholipids which include phosphatidyl choline (PC), phosphatidyl serine (PS), 
phosphatidyl ethanolamine (PE), phosphatidyl inositol (PI), and phosphatidic acid (PA).  
PC and PE are neutral Zwitterions, whereas PS, PA, and PI carry a negative charge. PI 
can be phosphorylated in the cell by phospholipid kinases to produce PIP, PIP2 and 
PIP3, which carry multiple negative charges on a single headgroup.  These PIs are 
locally concentrated in regions of the cell and act as signaling second messengers and 
substrates for proteins that localize to the plasma membrane.  There are no naturally 
basic phospholipids, and because of this, the levels of PS and PIs in the inner leaflet can 
confer a substantial negative charge (DiNitto, Cronin et al. 2003).   
The three phospholipids that were used in this dissertation are PC, PS, and PIP2 
(Figure 6).  The vesicles in our experiments were comprised of PC, which is neutral, 
and was used as a background.  PS was used as the standard negatively charged 
phospholipid in the inner leaflet of the plasma membrane.  It has an effective charge of 
negative one and is found in vivo at ~20-30%.  PIP2 is used as the primary multivalent 
phospholipid.  Its concentration at the plasma membrane is 100-fold greater than other 
poly-phosphatidylinositols, and it is the anchor for many membrane bound proteins, as 
well as a source for second messengers diacylglycerol (DAG) and inositol-1,4,5-
trisphosphate (Ins(1,4,5)P3). 
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Figure 6 Phospholipids 
  
Figure 6: Structures of the phospholipids used in this 
dissertation, from avantilipids.com.  Space filling models are 
shown above chemical structures.  Negative charges are 
identified by (-). 
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1.3.7 PIP2 
PIP2 is the major poly-phosphatidylinositol in mammalian cells. Its physical 
properties, organization and role in signaling are involved in many cell processes that 
occur at the membrane.  The biochemical and biophysical properties of this essential 
phospholipid and its interactions with proteins at the plasma membrane will be briefly 
reviewed here.  For a full review, refer to (McLaughlin, Wang et al. 2002). 
 
1.3.7.1 Structure and Charge 
PIP2 contains a DAG tail that is linked to the phosphate at the 1 position of an 
inositol ring that is also phosphorylated at the 4 and 5 positions.  The pK values are 6.7 
and 7.7 respectively.  The protonation states vary depending on the binding of proteins 
as well as the pH and ionic strength of the environment.  Consequently, the net charge 
of PIP2 can range from -3 to -4 due to the protonation states of these phosphate groups. 
 
1.3.7.2 Biological Roles of PIP2 
PIP2 was initially studied as the source of two second messengers in the cell, 
DAG and Ins(1,4,5)P3, which go on to activate PKC and release Ca
2+
 from the 
endoplasmic reticulum respectively.  It is now known that PIP2 is important for the 
membrane localization of proteins.  The attachment of these proteins to PIP2 is essential 
to their role in cytoskeleton dynamics, exocytosis, endocytosis, membrane trafficking, 
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and the activation of enzymes (Yin and Janmey 2003).  Many laboratories have 
proposed that the existence of high local concentrations of PIP2 within the cell are 
responsible for some of these functions.   PIP2 and other phosphaphatidylinositides are 
in fact distributed non-uniformly in the plasma membrane.  Moreover, PIP2 has been 
found to be abundant in certain regions of the plasma membrane, including stereocilia, 
membrane ruffles, macropinocytes, and nascent phagosomes (McLaughlin, Wang et al. 
2002; Huang, Lifshitz et al. 2004).  
 
1.3.7.3 PIP2 Concentration 
PIP2 is anabolized and catabolized by a number of different kinases, 
phosphatases, and lipases, and can also be sequestered by a plethora of PIP2 binding 
proteins in the cell (Figure 7). It comprises >99% of the doubly phosphorylated 
phosphatidylinositols in a mammalian cell, yet it makes up only ~1% of the 
phospholipids in the inner leaflet of the plasma membrane.  Assuming a typical cell 
with a radius of 10 µm has an effective total lipid concentration of 1 mM, the effective 
concentration of PIP2 would be ~10 μM (McLaughlin, Wang et al. 2002).  However, 
this would not be the concentration of PIP2 available since there are many proteins in 
the cell that bind to and sequester PIP2.  
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Figure 7 PIP2 metabolism 
 
  
Figure 7: A schematic of PIP2 metabolism adapted from (Rusten and 
Stenmark 2006).  Inositol rings of biological phosphoinositols are drawn 
with DAG attached to the Pi at the “1” position.  Arrows between structures 
are labeled with appropriate kinases and phosphatases. 
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1.3.8 Membrane Binding Domains 
There are numerous strategies that proteins have developed to bind to the 
membrane  (DiNitto, Cronin et al. 2003).  They range from the very specific binding 
interaction of phospholipase C delta pleckstrin homology (PLCδ-PH) domain with PIP2 
to the non-specific interaction of myristoylated alanine rich C kinase substrate 
(MARCKS).  To understand the localization and how myo1c functions at the 
membrane, it is essential to first understand how it is associated with the membrane.  
These two extremes of binding will be discussed below.  
 
1.3.8.1 MARCKS 
MARCKS contains a polybasic effector domain (ED) which binds to the plasma 
membrane (Figure 8).  The ED of MARCKS has been well studied, and contains 13 
basic residues, five phenylalanines, and a myristoylated N-terminus. MARCKS has no 
set structure when it is bound or unbound to the membrane (Arbuzova, Schmitz et al. 
2002).  MARCKS also binds to CaM and actin; these interactions, along with 
phosphorylation, inhibit it from binding to the membrane.  Myristoylation, hydrophobic 
insertions, and electrostatic interactions all contribute to membrane binding, and make 
MARCKS an eminent example for non-specific membrane association. 
Electrostatic interactions mainly contribute to MARCKS binding to the 
membrane.  This is accomplished by the polybasic region of the ED having an 
electrostatic attraction with the negatively charged inner leaflet of the plasma 
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membrane.  The negative charge is made up from PS and phosphatidyl inositols, the 
most abundant of which is PIP2.  These negatively charged lipids anchor the cluster of 
basic residues in the ED to the membrane.  Partition coefficients increase linearly in 
binding studies done with increasing the percent of acidic lipid (Arbuzova, Wang et al. 
2000; Lemmon and Ferguson 2001). 
These electrostatic interactions were found to be very non-specific.  The 
individual residues and lipids were inconsequential, as long as the residues were 
positively charged arginines or lysines, and the lipids were negative.  Studies done with 
R/K mutants and K/R mutants showed no effects on membrane binding (Wang, 
Gambhir et al. 2002).  It has also been shown that peptides with stretches of arginine or 
lysine bind just as well to a negative membrane as a protein made up with the same 
number of basic residues (Wang, Gambhir et al. 2002).  The only time this differs is 
when the protein has a rigid structure, and is able to make the same amount of contacts 
with fewer basic residues per total residues.  It has also been shown that MARCKS has 
no preference for PS or phosphatidyl glycine (PG), which has the same negative charge.  
However, MARCKS does bind preferentially to PIP2, as the partition coefficient is the 
same with 20% PS as it is with only 1% PIP2 (Wang, Arbuzova et al. 2001).  This 
preference for PIP2 over singularly charged phospholipids enables the polybasic ED of 
MARCKS to laterally sequester PIP2 into micro domains.  Through fluorescence 
experiments with physiological concentrations of 33% PS, MARCKS has been shown 
to bring together numerous PIP2 molecules (Wang, Gambhir et al. 2002). 
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Figure 8 MARKS peptide 
  
Figure 8: A representation of MARCKS binding to the plasma 
membrane, adapted from (Gambhir, Hangyas-Mihalyne et al. 
2004).  MARCKS is shown as a green snake.  The position of 
positively charged residues are denoted by white crosses.  N-
terminal myristoylation is represented by an orange squiggly 
tongue.   Brown hexagons are hydrophobic residues that insert 
into the membrane.  Lipids shown are: PC, white; PS, fuschia; 
PIP2, blue. 
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1.3.8.2 Pleckstrin Homology (PH) Domains  
PH domains are the 11th most common domain found in the human proteome 
(Lemmon 2007).  There are more than 250 proteins that contain one or more PH 
domains.  They were first identified in numerous membrane associated proteins with 
sequence homology to pleckstrin, a protein kinase C (PKC) substrate.  PH domains are 
made up of ~120 residues and contain a β-sandwich consisting of 7 β-strands.  This β-
core is capped at one open end by a C-terminal α-helix, leaving three hypervariable 
loops at the other end to interact with binding partners (Figure 9).  It was originally 
thought that all PH domains bound to phosphatidylinositols in cell membranes, although 
with varying affinities and specificities.  It is now known that some PH domains do not 
bind to phosphatidylinositols, but instead to proteins (Lemmon 2007).  An example of 
this is PHR1, which binds to the tail domains of myo1c and myoVIIa (Etournay, El-
Amraoui et al. 2005).   
Many PH domains contain a specific binding pocket for the phosphorylated 
inositol rings of phosphatidyl inositols.  These pockets are made up of multiple 
hypervariable loops that form hydrogen bonds to the phosphates on the inositol rings of 
phosphatidyl inositols (Figure 10) (Lemmon and Ferguson 2001).  The first of these 
loops between β-strand 1 and β-strand 2 is where the PH domain signature motif lies.  
Slight variations in the non conserved residues found on these loops give rise to the 
binding specificity to particular phosphatidyl inositols (Cronin, DiNitto et al. 2004).  
The binding pockets of poly-phosphoinoitol binding (PPB) PH domains can bind 
stereo-specifically to a specific phosphatidyl inositol, while others bind promiscuously 
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to many phosphatidyl inositols.  The crystal structures of many PH domains have been 
solved with the inositol phosphates bound in between the hypervariable loops.  
 
 
Figure 9 PLCδPH domain 
 
 
Figure 9: A crystal structure of PLCδ-PH domain bound to 
Ins(1,4,5)P3 imposed in a model plasma membrane.  The inositol 
from the crystal structure represents the blue head domain of 
PIP2.  The structure of PLCδ-PH was drawn with Pymol. 
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Figure 10 PH domain H-bonds 
  
Figure 10: A close up of the crystal structure from Figure 9 drawn 
with Pymol.  Details are shown of hydrogen bonds from arginines 
and lysines in hypervariable loop one to the phosphates on 
Ins(1,4,5)P3.  
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2 Materials and Methods 
This chapter will discuss all of the materials, equipment, and methods used to 
complete this thesis including: equipment, reagents and buffers, molecular biology, 
tissue culture, protein detection, protein preparations, assays, analysis of data, and 
modeling. 
 
2.1 Equipment 
Fast phase liquid chromatography (FPLC), ÄKTA Basic UPC (Amersham 
Biosciences);  fluorimeter, (PTI, Birmingham, NJ); UV-visible spectrophotometer, Cary 
50 Bio (Varian); microscope setup: Leica DMIRB microscope fitted with a Nikon 1.45 
NA objective lens (Axelrod, 2001), 488 nm 43 series argon laser (Melles Griot), C4742-
95 digital camera (Hamamatsu), computer controlled filter wheel (Sutter Instruments); 
centrifuges: TL ultracentrifuge (Optima), L8-M ultracentrifuge (Beckman), RC-5B 
superspeed centrifuge (Sorvall), J6-HC swinging bucket (Beckman); gel scanner, 8600 
imager (Typhoon); scintillation counter, LS 6000 SC (Beckman); film developer, X-
OMAT 2000A Processor (Kodak); Orbital Shaker (Forma Scientific). 
 
2.2 Reagents and Buffers 
All in vitro experiments were performed in HNa100 (10 mM HEPES, pH 7.0, 
100 mM NaCl, 1 mM EGTA, 1 mM DTT) unless otherwise stated.  Ca
2+
 concentrations 
were adjusted by adding CaCl2 to HNa100 and are reported as free Ca
2+
 using EGTA as 
a chelator.  Unless stated otherwise, all experiments done with myosin constructs 
containing at least one IQ motif were performed with 1 M free CaM.  
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Phosphatidylserine (PS), phosphatidylcholine (PC), and phosphatidylinositol-4,5-
bisphosphate (PIP2) were purchased from Avanti Polar Lipids (Alabaster, AL); D-myo-
inositol-1,4,5-trisphosphate (Ins(1,4,5)P3), D-myo-inositol-1,3,4,5-tetrakisphosphate 
(Ins(1,3,4,5)P4), D-myo-inositol-1,3,4,6-tetrakisphosphate (Ins(1,3,4,6)P4), and D-myo-
inositol hexakisphosphate (InsP6) were purchased from Calbiochem (La Jolla, Ca); D-
myo-inositol-3-monophosphate (Ins(3)P1) D-myo-inositol-1,3,4-trisphosphate 
(Ins(1,3,4)P3), and D-myo-inositol-1,2,6-trisphosphate (Ins(1,2,6)P3) were purchased 
from Cayman Chemical (Ann Arbor, MI); D-myo-inositol-1,2,5,6-tetrakisphosphate 
(Ins(1,2,5,6)P4) and D-myo-inositol-1,2,3,5,6-pentakisphosphate (Ins(1,2,3,5,6)P5) were 
purchased from A.G. Scientific (San Diego, Ca).  Tritiated inositol-1,4,5-trisphosphate 
(
3
H-Ins(1,4,5,)P3) was purchased from Perkin Elmer.  Anti-GFP rabbit serum was 
purchased by Invitrogen.  Secondary antibodies, ECL anti-rabbit IgG and anti-mouse 
IgG were purchased from Amersham Biosciences.   
 
2.3 Molecular Biology 
2.3.1 Constructs 
 All constructs used are listed along with their domain structure (Figure 11).  
Myo1c-tail, myo1c (residues 690-1028); myo1c-motor, myo1c (residues 1-767); GFP-
myo1c, GFP-tagged full length myo1c; GFP-tail, GFP-tagged myo1c (residues 690-
1028); GFP-tail
IQ2–3
, GFP-tagged myo1c (residues 721-1028); GFP-myo1c-tail
IQ3
, GFP-
tagged myo1c (residues 744-1028); GFP-myo1c-tail
IQ0
, GFP-tagged myo1c (residues 
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768-1028); GFP-tail-K892A and GFP-tail-R903A, point mutations in GFP-myo1c-tail; 
GFP-myo1c-K892A and GFP-myo1c-K903A, point mutations in GFP-myo1c. 
 
Figure 11 Constructs 
  Figure 11:  Domain structures of myo1c constructs 
used in this thesis. 
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2.3.2 DNA Handling 
All DNA was amplified in competent DH5α cells.  Cells were grown in 2xYT 
media (171 mM NaCl, 16 g/mL tryptone, 10 g/mL yeast extract) in an orbital shaker 
overnight at 37 °C, 250 RPM.  Transformations were done by adding 0.5 µg DNA to 50 
µL DH5α cells in a pre-chilled microcentrifuge tube and incubating on ice for 20 
minutes.  Reactions were heat pulsed at 42 °C for 45 seconds and placed on ice for 2 
minutes.  500 µL of 2xYT was added to each tube and tubes were incubated at 37 °C for 
1 hour with shaking at 250 rpm.  Cells were placed on appropriate agar plates or 
transferred to larger cultures containing either 100 µg/mL ampicillin or 30 µg/mL 
kanamycin.  DNA plasmids were purified using Promega Wizard Plus mini and midi 
kits for 1.5 and 50 mL cultures respectively.  DNA concentrations were calculated by 
measuring absorbance in a UV-Vis spectrophotometer at 260nm, based on one A260 
O.D. unit for dsDNA = 50 µg/ml. 
 
2.3.3 Sequencing and Primers 
All primers for DNA sequencing and point mutations were designed by hand 
and ordered through Invitrogen (Life Technologies).  DNA sequences were verified by 
automated dideoxynucleotide sequencing at the University of Pennsylvania DNA 
sequencing facility. 
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2.3.4 Mutations 
Point mutations in GFP-myo1c-tail (GFP-tail-R903A and GFP-tail-K896A) or 
full length GFP-myo1c (GFP-myo1c-K892A and GFP-myo1c-R903A) were generated 
using the Quick-Change Site-Directed Mutagenesis Kit according to the manufacturer’s 
protocol (Stratagene Cloning Systems, La Jolla, California).  Forward and reverse 
primers were designed containing single amino acid mutations to overlap desired sites 
with melting temperatures over 78 °C.  A thermo cycling reaction was performed for 16 
cycles, followed by the addition of 10 U of DpnI and an hour incubation at 37 °C to 
digest parent DNA.  Each reaction was transformed into XL1-Blue cells and plated on 
agar plates containing the appropriate antibiotic.  Successful plates yielded, on average, 
10-100 colonies.  All point mutations were verified by automated dideoxynucleotide 
sequencing. 
 
2.4 Tissue Culture 
2.4.1 Cell Types 
We used a number of different mammalian cell types for the investigations in 
this thesis.  Normal rat kidney (NRK) epithelial cells were the primary cell type used for 
our TIRF/FPAP experiments, as well as in many of our fluorescence imaging studies.  
African green monkey kidney (COS-7) cells, Chinese hamster ovary (CHO) cells, and 
HeLa cells were used in myo1c localization studies.  Human embryonic kidney (293T) 
cells were used primarily for small scale protein growths. 
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2.4.2 Growth and Passaging 
All cells types were grown in a 37 °C humidified incubator in 5% CO2. Cells 
were maintained in growth medium, Dulbecco's Modification of Eagle's Medium 
(DMEM) containing 10 % Fetal Bovine Serum (FBS), 100 U/ml penicillin, 100 µg/ml 
streptomycin, and 0.25 µg/ml amphotericin B, in 10-cm round tissue culture plates.  
Cells were passaged 1:10 using 0.25% trypsin-EDTA when 80-100% confluent, which 
occurred in 2-4 days, depending on the cell type.  Frozen, 1 mL aliquotted stocks in 
DMEM with 15% FBS and 10% DMSO at 5x the normal passaging concentrations 
were made for all cell types. 
 
2.4.3 Transfections 
NRK and COS-7 cells were transfected using transient electroporation.  
Approximately five million cells were trypsinized from a 10-cm plate and resuspended 
in 400 µL cold DMEM.  10 µg DNA was added and cells were transferred to a 0.4-cm 
electroporation cuvette and incubated on ice for 5 minutes.  Cells were electroporated in 
a Bio Rad Gene Pulser II at 250 V, 950 µF for NRK cells, and 200 V, 950 µF for COS-
7 cells.  Cells were immediately transferred to 60-mm plates with cover slips in 3 mL 
growth media and incubated at 37 °C.  Media was removed 4-6 hours later and cells 
were incubated with fresh growth media overnight.  To avoid apparent aggregation of 
GFP-myo1c-tail
IQ0
, cells electroporated with this construct were grown overnight at 32 
°C (Tang and Ostap 2001). 
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 HeLa, CHO, and 293T cells were transfected with Lipofectamine™ 2000.  Cells 
were grown in either 60-mm plates on top of cover slips or 15-cm plates until 95% 
confluent at time of transfection.  For a 60-mm plate, 8 µg DNA in 0.5 mL DMEM was 
mixed with 10 µL Lipofectamine™ 2000 diluted in 0.5 mL DMEM and incubated for 
20 minutes at room temperature.  For 15-cm plates, all reagents were scaled up 
according to surface area.  The DNA and Lipofectamine™ 2000 complex was added to 
the cells and incubated overnight at 37 °C. 
 
2.4.4 Fixing and Mounting Slides 
To fix and mount cells for viewing with immunostaining or 
rhodamine/phalloidin, a 4% paraformaldehyde fixative was added to cells adhered to a 
cover slip for 15 minutes.  Cells were washed with PBS and permeablized in a 0.1% 
Igepal solution for 10 minutes, then washed with PBS and blocked in a 1% BSA 
solution with or without 1:1000 dilution of rhodoamine/phalloidin for 30 minutes.  Cells 
were then placed in permeablization buffer with 10 µg/mL primary antibody and 
incubated for 1 hour, and washed and incubated in 1:500 dilution of secondary antibody 
in permeablization buffer for 1 hour.  Mounting solution was made by combining 120 
µL of 0.017 g PPD, 1.5 mL 7.5% NaHCO3, 0.3 mL 0.5 M Na2CO3 with 100 µL of 10x 
PBS + 780 µL 50% glycerol and pipetting 12 µL onto a clean slide.  Cover slips were 
lowered onto slides with mounting solution and sealed on all sides with red nail polish.  
Before use, all antibodies were spun down at maximum speed in a microcentrifuge tube 
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centrifuge for 5 minutes at 4°C to remove particulates.  All solutions were made up in a 
PBS solution containing Ca
2+
 and Mg
2+
. 
 
2.5 Protein Detection 
2.5.1 Determining Protein Concentration 
All protein concentrations were determined with the Bradford assay using 
Coomassie Plus (Pierce).  Five standards were made containing 0, 2.5, 5, 10, and 20 ng 
BSA in 95 µL total volume.  5 µL of protein buffer was added to each tube.  Samples 
were then made up by adding 5 µL protein to 95 µL H2O in duplicate.  After adding 1.5 
mL of Coomassie Plus, each tube was vortexed for 5 seconds.  Absorbance at 595 nm 
was measured using a UV-visible spectrophotometer.  Standards were fit to a linear line 
and that line was used to determine protein concentration. 
 
2.5.2 Western Blots 
For detection of proteins by Western blot analysis, proteins were run on an SDS-
PAGE gel and then transferred to a Hybond-C Extra nitrocellulose membrane 
(Amersham Biosciences) in Towbin buffer (25 mM Tris, 192 mM glycine, 10% 
methanol, 0.1% SDS) for 1 hour at 100 mV.  The membrane was subjected to a series of 
three 60 minute agitated incubations in blocking buffer, which was comprised of a 5% 
milk solution in wash buffer (50 mM Tris, 150 mM NaCl, 0.05% Igepal, pH 8.0), 
primary IgG antibody, and horseradish peroxidase linked ECL secondary-antibody IgG 
(Amersham Biosciences).  All antibodies were diluted in blocking buffer and thorough 
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washings were done between each incubation.  Following incubations, the membrane 
was incubated in Super Signal West Pico chemiluminescent substrate (Pierce) for 5 
minutes and then either placed in a developing cartridge and exposed to Kodak Blue 
XB-1 film, or imaged using a gel scanner. 
 
2.5.3 SYPRO® Red 
For quantitative analysis of nanogram levels of proteins run on gels, we used 
SYPRO® Red protein gel stain.  Proteins were run on an SDS-PAGE gel and agitated 
with SYPRO diluted 1:5000 in 7.5% acetic acid for 50 minutes.  Gels were destained in 
7.5% acetic acid for 10 minutes before being imaged on a gel scanner. 
 
2.6 Protein Purification 
2.6.1 Mouse Myo1c-Tail 
The mouse myo1c-tail (accession # NM_008659) construct (residues 690 – 
1028), which consists of an N-terminal HIS6 tag for purification, three CaM-binding IQ 
motifs, and the tail domain, was expressed and purified from Sf9 cells as reported 
(Tang, Lin et al. 2002).  Myo1c-tail with bound CaM was purified from Sf9 cells that 
were co-infected with virus-containing recombinant myo1c-tail
 
and CaM.  Four liters of 
cells were suspended in 300 mL of 25 mM Tris, pH 7.5, 20
 
mM imidazole, 300 mM 
NaCl, 0.5% Igepal, 0.5 mM EGTA, 1 mM 2-mercaptoethanol,
 
1 mM PMSF, 
0.01 mg/mL aprotinin, and
 
0.01 mg/mL leupeptin at 4 °C and homogenized with five 
strokes
 
in a Dounce homogenizer.  Cell extract was centrifuged at 100,000
 
× g for 1 h.  
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The supernatant was sonicated five times for 15
 
s, incubated with 10 µg/ml RNase A 
and 5 µg/ml DNase I on ice
 
for 15 min, and loaded on to two 2 mL nickel-
nitrilotriacetic acid (Qiagen)
 
columns.  The columns were washed with five column 
volumes of the same
 
buffer without Igepal.  Myo1c-tail was eluted with 5 ml of 125
 
mM 
imidazole, 300 mM NaCl, 25 mM Tris pH 8.0, 0.5 mM EGTA, 1
 
mM 2-
mercaptoethanol, 0.01 mg/ml aprotinin, 0.01 mg/ml leupeptin,
 
and 5 µM CaM from 
each column.  The elutions were diluted in 30 ml
 
of 10 mM HEPES pH 7.0, 200 mM 
NaCl, 1 mM EGTA, and 1 mM 2-mercaptoethanol
 
and loaded on to a MonoS column 
(Amersham Biosciences) equilibrated
 
in 10 mM HEPES, 50 mM NaCl, 1 mM EGTA, 
and 1 mM DTT.  Myo1c-tail
 
was separated and eluted with a linear 50 mM - 1 M NaCl 
gradient.
  
Myo1c-tail with bound CaM elutes at ~ 400 mM NaCl.  Fractions
 
containing 
myo1c-tail were combined and dialyzed versus 10 mM Tris,
 
pH 8.0, 50 mM NaCl, 
1 mM EGTA, and 1 mM DTT and loaded on to MonoQ
 
column (Amersham 
Biosciences) equilibrated in 10 mM Tris, pH 8.0,
 
50 mM NaCl, 1mM EGTA, and 1 mM 
DTT.  Myo1c-tail was eluted with a
 
linear 50 mM - 1 M NaCl gradient.  Myo1c-tail 
with bound
 
CaM elutes at ~ 380 mM NaCl.  Fractions containing myo1c-tail
 
were 
combined and concentrated to approximately 1.5 mL using Microsep
 
concentrators (Pall 
Filtron) or Ultra-15 Centrifugal Filter Units (Amicon).  The concentrated protein was 
dialyzed
 
versus HNa100 overnight.  Myo1c-tail concentrations were determined using
 
Coomassie Plus as described above.  A typical yield of myo1c-tail with bound CaM 
from 4 liters
 
of cells was ~1
 
mg.  The purified myo1c-tail contains three bound CaM.  A 
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typical gel showing various stages of the myo1c-tail purification is shown from Tang et 
al. 2002 (Figure 12). 
 
 
Figure 12 Purification of myo1c-tail 
  
 
  
Figure 12: A Coomassie-stained SDS-PAGE gel of the purification of myo1c-
tail from (Tang, Lin et al. 2002).  Lane 1) nickel-nitrilotriacetic acid column 
elution.   Lanes 2) mono-S elution, and 3) mono-Q elution.  Arrows specify 
location of molecular mass markers. The calculated molecular mass of myo1c-
tail is 39 kDa.  
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2.6.2 Mouse Myo1c-Motor 
The myo1c-motor construct (accession # NM_008659) includes the motor 
domain and 3 IQ motifs (residues 1 - 767).  A 15 amino acid sequence for site-specific 
biotinylation (Schatz 1993) and a FLAG sequence for purification were inserted at the 
C terminus.  Myo1c-motor was expressed and purified from Sf9 cells that were co-
infected with virus containing recombinant myo1c-motor and CaM (El Mezgueldi, 
Tang et al. 2002).  Four liters of cells were suspended in 250 mL of 10 mM Tris, pH 
7.5, 200 mM NaCl, 4 mM MgCl2, 2 mM ATP, 5 mM DTT, 0.5% Igepal, 1 mM EGTA, 
1 mM PMSF, 0.01 mg/ml aprotinin, and 0.01 mg/ml leupeptin at 4 °C and homogenized 
with five strokes in a Dounce homogenizer.  Cell extract was centrifuged at 100,000 × g 
for 1 h.  Supernatant was loaded onto two 1.5 mL FLAG resin columns.  The columns 
were washed with five column volumes of the same buffer without Igepal, then two 
column volumes of buffer without Igepal or ATP.  Myo1c-motor was eluted with 5 ml 
of 100 mM NaCl, 10 mM Tris, pH 8.0, 1 mM EGTA, 1 mM DTT, 0.01 mg/ml 
aprotinin, 0.01 mg/ml leupeptin, 0.2 mg/mL FLAG peptide, and 5 µM CaM from each 
column.  Eluted protein was loaded on to a MonoQ column (Amersham Biosciences) 
equilibrated in 10 mM Tris, pH 8.0, 50 mM NaCl, 1mM EGTA, and 1 mM DTT.  
Myo1c-motor was eluted with a linear 50 mM - 1 M NaCl gradient.  Myo1c-motor with 
bound CaM eluted at ~ 430 mM NaCl.  Fractions containing myo1c-motor were 
combined and dialyzed versus 50% glycerol, 50% HNa100.  Myo1c-motor 
concentrations were determined using Coomassie Plus as described above.  A typical 
yield of myo1c-motor with bound CaM from 4 L of cells was ~2 mg.  The purified 
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myo1c-motor contained three bound CaM.  A typical gel showing various stages of the 
myo1c-motor purification is shown (Figure 13). 
 
 
 
Figure 13 Purification of myo1c-motor 
  
Figure 13: A Coomassie-stained SDS-PAGE gel of the purification of 
myo1c- motor.  Lanes 1-4) Elutions from FLAG resin column.  Lanes 
5-14) Elutions from Mono-Q column.  Arrows specify location of 
molecular mass markers. The calculated molecular mass of myo1c-
motor is 89 kDa. 
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2.6.3 Calmodulin (CaM) 
Recombinant chicken CaM was expressed and purified from bacterial lysates 
using a phenyl sepharose column in the presence of EDTA, and then CaCl2 (Putkey, 
Slaughter et al. 1985), and further purified by FPLC using a MonoQ column 
(Amersham Biosciences).  This final MonoQ step was crucial, since we found a 
bacterial contaminant present in very low abundance (Figure 14) that effectively 
competed with myo1c-tail for binding to anionic lipids (Hokanson and Ostap 2006). 
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Figure 14 Purification of CaM 
  
Figure 14: A SYPRO red-stained SDS-PAGE gel of pellet samples from a 
sedimentation assay of CaM with 60% PS LUVs.  Lane 1) 60% PS LUVs control.  
Lanes 2-3) 60% PS LUVs with CaM, 50 and 100 µM.  Lanes 4-5) 60% PS LUVs 
with CaM, 50 and 100 µM, after purification with Mono-Q.  Note the high 
molecular weight contaminants in lanes 2-3.  Arrows specify location of molecular 
mass markers. The calculated molecular mass of CaM is 16 kDa. 
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2.6.4 Glutathione-S-Transferase (GST) 
GST was used to block non-specific interactions and was purified from BL21-
pLys cells.  BL21-pLys cells were transfected with a pGEX.B23 vector containing 
GST.  Cell cultures of 2.5 L were grown containing 100 µg/mL ampicillin and 34 
µg/mL chloramphenacol and induced with 1 mM IPTG for 3 hours after cells reached 
an OD of 0.7 at 600 nm.  Cells were harvested by centrifugation for 20 minutes at 
10,500 x g.  The pellet was resuspended in 100 mM NaCl and spun at 5000 x g in a 50 
mL conical tube for 15 minutes.  The pellet was then flash frozen in liquid N2 and 
stored at -80 ºC.  The frozen cell pellet was resuspended in 50 mL of PBS (1.4 mM 
NaCl, 27 mM KCl, 101 mM Na2HPO4, 18 mM KH2PO4), 1 mM DTT, 1 mM PMSF, 
and 1% triton at 4 °C.  The lysate was sonicated for 15 seconds five times and 
centrifuged for 30 minutes at 27,000 x g.  The supernatant was loaded onto a 2.5 mL 
Glutathione Sepharose 4B matrix column immediately after the spin and washed with 
five column volumes of PBS with 1 mM DTT.  GST was eluted with two column 
volumes of reduced glutathione buffer (10 mM glutathione, 50 mM Tris, pH 8.0).  2.5 
mL of bacterial cells typically yielded ~ 100 mg GST.  A typical gel showing various 
stages of the GST purification is shown (Figure 15). 
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Figure 15 Purification of GST 
  
Figure 15: A Coomassie-stained SDS-PAGE gel of the purification of 
GST.  Lane 1) Lysis from BL21 cells.  Lane 2) Supernatant from 
sedimentation.  Lane 3) Wash from glutathione sepharose column.  Lane 4) 
Elution from glutathione sepharose column.  Lane 5) Blank.  Lane 6) 100 x 
dilution of elution from glutathione sepharose column.  Arrows specify 
location of molecular mass markers. The calculated molecular mass of 
GST is 29 kDa. 
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2.6.5 Fibrinogen 
Lyophilized fibrinogen was a gift from Dr. Paul Janmey (University of 
Pennsylvania) and was rehydrolyzed in HNa100, aliquotted into 1 mL samples, frozen 
in liquid N2, and stored at -80 ºC.  The final concentration for fibrinogen was ~8 mg/mL 
with 3% fibronectin present. 
 
2.6.6 Phospholipase-Cδ Pleckstrin Homology Domain (PLCδ-PH) 
A bacterial expression plasmid for the PH domain of phospholipase-Cδ 
(residues 11 – 140; PLC-PH) was a gift from Dr. Mark Lemmon (University of 
Pennsylvania) and was purified as described (Ferguson, Lemmon et al. 1994). BL21 
(DE3) RP cells were transfected with a pGEX.B23 vector containing PLC-PH.  Cells 
were grown in 4 L cultures containing 100 µg/mL ampicillin and 34 µg/mL 
chloramphenacol and induced with 1 mM IPTG for 3 hours when cells reached an OD 
of 0.7 at 600 nm.  Cells were harvested by centrifugation for 20 minutes at 10,500 x g, 
and the pellet was resuspended in 100 mM NaCl and spun at 5000 x g in a 50 mL 
conical tube for 15 minutes.  The pellet was frozen in liquid N2 and stored at -80 ºC.  
Upon removal from storage, the pellet was resuspended in 50 mL 100 mM NaCl, 50 
mM glucose, 25 mM MES, pH 6.0, 5 mM DTT, and 1 mM PMSF.  The lysate was 
sonicated five times for 15
 
s and centrifuged for 30 minutes at 27,000 x g.  The 
supernatant was loaded onto a pre-equilibrated 60 mL DEAE cellulose column and 
washed with two column volumes of 25 mM MES pH 6.0, 50 mM NaCl, 1 mM DTT, 
and 1 mM PMSF.  All flow through was collected and diluted 3-fold with 25 mM MES 
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pH 6.0, and 1 mM DTT and then loaded directly onto a pre-equilibrated S-sepharose 
column.  The S-sepharose column was washed with two column volumes of 25 mM 
MES, pH 6.0, and 1 mM DTT, and then the protein was eluted in 6 mL fractions with a 
250 mL linear salt gradient from 0-500 mM NaCl.  The protein eluted from this column 
at ~ 120 mM NaCl.  Fractions containing PLC-PH, as determined by the OD at 280 
nm and a SDS-PAGE gel, were pooled and ammonium precipitated to 75% saturation, 
0.476 g/mL NH4SO4, overnight at 4 ºC.  The precipitate was centrifuged at 17,000 x g 
for 15 minutes and the pellet was resuspended in a minimal volume of 25 mM MES pH 
6.0, 150 mM NaCl, and 1 mM DTT by gentle mixing.  The protein was aliquotted into 
microcentrifuge tubes and centrifuged at maximum speed for two minutes to pellet 
particulates.  The protein was syringe filtered through a 0.22 µm filter and loaded onto a 
Superdex 200 gel filtration column.  PLC-PH ran as a 20 kDa protein.  The fractions 
containing protein, as determined by SDS PAGE gel, were pooled together and dialyzed 
overnight versus 2 L HNa100.  The protein solution was concentrated using Microsep
 
concentrators (Pall Filtron) and aliquotted into 50 µL samples that were frozen in liquid 
N2 and stored at -80 ºC.  A typical gel showing various stages of the purification of 
PLC-PH is shown (Figure 16). 
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Figure 16 Purification of PLCδ-PH 
  Figure 16: A Coomassie-stained SDS-PAGE gel of the purification of PLCδ-PH.  
Lane 1) Supernatant of lysed cells.  2) Pellet of lysed cells.  3) Elution from DEAE 
column.  4) Elution from S-Sepharose elution.  5) Elution from gel filtration 
column.  Arrows specify location of molecular mass markers. Lanes are non-
continuous and are taken from 2 gels of the same protein preparation.  Lanes from 
elutions with little or no protein have been excluded.  The calculated molecular 
mass of PLCδ-PH is 20 kDa.  
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2.6.7 GFP-Tagged Myo1c-Tail 
Small amounts of GFP-tail, GFP-tail-K892A and GFP-tail-R903A were purified 
for binding experiments by transient expression in HEK-293T cells (Hokanson, Laakso 
et al. 2006).  Transfected cells (~1x10
9
 cells per transfection) were collected by 
sedimentation, flash frozen in liquid N2, and stored at -80 C.  GFP-proteins were 
purified in a 1-day procedure.  Pellets of ~1x10
9
 cells were suspended in 15 mL lysis 
buffer (10 mM HEPES pH 7.0, 1 mM EGTA, 300 mM NaCl, 5mM DTT, 0.5% Igepal, 
1mM PMSF, 0.01 mg/mL aprotinin, and 0.01 mg/mL leupeptin), lysed by 8 strokes in a 
Dounce homogenizer, and centrifuged for 1 hour at 100,000 x g.  The supernatant was 
incubated on ice with 10 µg/mL RNase A and 5 µg/mL DNase I for 20 minutes.  After 
dilution, the final NaCl concentration of the supernatant was 100 mM; the supernatant 
was then passed through a 0.22 µm syringe filter and loaded immediately onto a 
MonoQ column (Amersham Biosciences).  Protein was eluted from the MonoQ column 
using a linear salt gradient, and GFP-proteins were detected by monitoring GFP 
fluorescence.  Fractions containing GFP were diluted to 100 mM final NaCl 
concentration, and CaCl2 was added to attain 1 mM free Ca
2+
.  The protein was loaded 
immediately back on the MonoQ column and eluted with a linear salt gradient in 
column buffers containing 1 mM free Ca
2+
.  The addition of Ca
2+
 results in the 
dissociation of a CaM from myo1c (Zhu, Beckingham et al. 1998; Sokac and Bement 
2000).  We found that this CaM dissociation causes the GFP-proteins to elute from the 
MonoQ column at a lower salt concentration, resulting in their separation from Ca
2+
-
insensitive proteins.  5 µM CaM and 5 mM EGTA were immediately added to the 
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eluted GFP-proteins, and the proteins were dialyzed overnight versus HNa100.  GFP-
tail, GFP-tail-K892A, and GFP-tail-R903A were > 90% pure as determined by SYPRO-
red staining of SDS-PAGE gels (Figure 17).  GFP-proteins were stored on ice and used 
in binding assays within 2 days of purification.  Yields of pure GFP-proteins were low 
(2 – 3 µg per transfection), but the preparations provided enough material to perform 
binding assays.  A Western blot analysis with anti-GFP is shown (Figure 17 inset). 
293T cells transfected with GFP-myolc-tail were also lysed and purified in the 
presence of phosphatase or phosphatase inhibitors.  Phosphatase inhibitor was added to 
293T cells during pellet resuspension and lysis.  Cells lysates were then separated into 
two fractions; 400 U/µL of lambda protein phosphatase was added to one, then both 
fractions were purified separately as described above.  
 
Figure 17 Purification of GFP-tail constructs 
Figure 17: A SYPRO-red stained 
SDS-PAGE gel showing purified 
GFP-tail constructs.  Lane 1) GFP-
tail.  Lane 2) GFP-tail-R903A.  Lane 
3) GFP-tail-K892A.  Bottom) 
Western blot of purified GFP-myo1c-
tail constructs stained with anti-GFP 
antibody.  Figure originally published 
in (Hokanson, Laakso et al. 2006). 
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2.6.8 Mouse Myo1c-Tail Monoclonal Antibody (M2) 
Frozen hybridoma cells containing a monoclonal antibody for the epitope 
PVVKYDRKGYKPRPRQLLL in mouse myo1c (M2), a gift from Peter Gillespie 
(Oregon Health and Science University, Portland, Oregon), were rapidly thawed and 
transferred to 5 mL warm RPMI 1640 medium containing 10% FBS and 1:100 
penicillin and streptavidin.  Cells were started in a 6-cm tissue culture plate and split 1:5 
into larger volume plates each time cell densities reached 1 million cells/mL until cell 
volume reached 0.5 L.  Supernatant was collected by centrifuging cells at 2500 x g for 5 
minutes at 4 °C.  The supernatant was filtered through a 0.22 µm filter and loaded onto 
a pre-equilibrated 1 mL HiTrap Protein G HP column (GE healthcare) at 4 °C.  The 
HiTrap column was washed with 20 mL PBS and the protein was eluted with 5 mL 100 
mM glycine pH 2.5 into 0.5 mL fractions containing 25 µL 1 M Tris pH 9.5 to 
neutralize the pH.  Fractions were run on an SDS-PAGE gel; those containing antibody, 
with bands appearing at 30 and 50 kDa (Figure 18), were pooled and dialyzed verses 2 
L PBS overnight, followed by 6 hours versus 500 mL 50% PBS, 50% glycerol.  
Supernatants collected from a 500 mL preparation yielded ~ 1.5 mg antibody. 
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Figure 18 Purification of M2 antibody 
 
  
Figure 18: A Coomassie-stained SDS-PAGE gel of the purification 
of M2.  Lanes 1-7) Elutions of HiTrap column.  Arrows specify 
location of molecular mass markers.  The calculated molecular mass 
of the light and heavy chain subunits of an antibody are ~30 and 
50 kDa.  
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2.7 Assays 
2.7.1 Lipid Preparation 
Lipid components were mixed in the desired ratios in chloroform and dried 
under a stream of nitrogen.  Phospholipid vesicles containing PIP2 were also prepared 
by first placing the methanol/water/chloroform solution in a 35 C water bath for five 
minutes and then applying maximum vacuum in a rotovap for 30 minutes to ensure 
uniform inclusion of PIP2 and PC (Gambhir, Hangyas-Mihalyne et al. 2004).  This 
method was used to ensure that all of the chloroform was removed from the lipid 
samples; however, we found that LUVs formed using either of these two methods were 
identical, and therefore, we primarily prepared LUVs using a stream of N2 gas.  
 
2.7.2 Sucrose-Loaded LUVs 
Large unilamellar vesicles (LUVs) with 100 nm diameter were prepared by 
extrusion (Hokanson and Ostap 2006).  Lipids to be used in sedimentation experiments 
were resuspended in 176 mM sucrose, 12 mM HEPES pH 7.0, to a total concentration 
of 1 or 2 mM.  This solution was used to increase the density of the LUVs so they 
would form a pellet in our sedimentation assays while maintaining the same osmolarity 
as our HNa100 buffer.  Five cycles of rapid freeze-thaw using ethanol/dry-ice and a 37 
°C water bath, followed by a one minute incubation in a bath sonicator, were applied 
before passing each lipid solution through a 100-nm filter (11 times) using a mini-
extruder (Avanti Polar Lipids).  LUVs were dialyzed overnight versus HNa100.  LUVs 
were stored at 4C under N2 gas and discarded after 3 days.  PS and PIP2 percentages 
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reported throughout the text are the mole percentages of total PS and PIP2 in a 
background of PC.  Lipid concentrations are given as total lipid unless otherwise noted.  
We checked that the diameter of our LUVs were uniformly 100 nm, by using 
dynamic light scattering (DLS) to measure the dispersion of sizes. LUVs were 
consistently found to be 100 nm in diameter with very little dispersion. We did find that 
under high divalent cation levels, such as Ca
2+
, the dispersion of LUV sizes tended to 
increase as well as the average size of LUVs (Figure 19) due to a known effect of Ca
2+
 
to the lipid vesicle structure (Bentz and Duzgunes 1985). 
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Figure 19 Ca
2+
 effect on DLS of LUVs 
 
  
Figure 19: A histograph of the distribution of LUVs by DLS.  
Size distribution of 2% PIP2 LUVs with 0 mM (black bars), 10 
µM (hashed bars), or 100 µM Ca
2+
 (open bars) by DLS.  
Frequency of radii from 28 scans per each sample is shown.  
Note that the addition of Ca
2+
 causes the size distribution to 
shift to the right and become more dispersed. 
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2.7.3 Phosphorous Assay 
To check that the concentrations of LUVs we were calculating were correct, we 
determined the total amount of phosphorous in a typical LUV sample following a 
modified procedure of Fiske & Subbarow from Avanti Polar Lipids (Fiske and 
Subbarow 1925).  We used 0 - 0.0456 µmoles KH2PO4 to make phosphorous standards 
along with our samples of LUVs made up of various lipids.  Solvent was removed with 
a stream of N2 and 90 µL of 8.9 N H2SO4 was added to each tube.  All samples were 
heated to 210 ºC in an aluminum heating block for 25 minutes.  Tubes were removed 
and left to cool for 5 minutes before adding 30 µL of H2O2.  Tubes were reheated at 210 
ºC for 30 minutes, then allowed to cool to ambient temperature before adding 780 µL of 
H2O.  We then added 100 µL of 2.5% ammonium molybdate tetrahydrate solution and 
again vortexed each tube five times.  We next added 100 µL of 10% ascorbic acid and 
vortexed each tube five times.  A marble was placed over each tube to minimize 
evaporation and tubes were heated to 100 ºC for seven minutes.  Absorbance of 
standards was measured at 820 nm using a UV/Visible spectrophotometer and used to 
generate a linear calibration curve to determine the concentration of phosphorous in 
each LUV sample.  Predicted concentrations of LUVs were found to be accurate within 
5%. 
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2.7.4 Sedimentation Assay 
To test the binding of myo1c-tail to LUVs, we sedimented LUVs in a TLA100 
rotor (Beckman), with a rave of 3.45 cm at 63,000 rpm to produce forces of 150,000 x g 
according to: 
Equation 1 
𝑔𝑐𝑒𝑛 =
(𝜔)2𝑟
𝑔
 
 where ω is the angular velocity in revolutions per second, r is the average radius of the 
rotor, and g is a gravitational constant of 980 cm/s
2
. 
 
2.7.4.1 Defining Pellet 
We determined that sucrose loaded LUVs sedimented to the bottom 10% of a 
centrifuge tube when centrifuged at 150,000 x g after 20 minutes, but that they do not 
form a stable pellet.  200 µL samples of LUVs made with 5% dansyl labeled PS were 
centrifuged at 150,000 x g for 30 minutes.  Five samples at sequential depths were 
carefully extracted from each centrifuge tube. We checked the samples for fluorescence 
at 340:500-620 nm and found that no lipid was found in the top 90% of the tube, but 
~100% of the expected lipid was found in the bottom 10% (Figure 20).  Following 
removal of the supernatant, HNa100 was added to the tubes to suspend any pellet; no 
florescence was found in this sample.  This experiment was repeated with LUVs that 
did not contain dansyl labeled lipids, but were monitored by total phosphorous as 
described above; the results were identical.  We thus define the “pellet” as the bottom 
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20% of the sample in a centrifuge tube after a 30 minute spin at 150,000 x g for all of 
our sedimentation assays. 
 
 
Figure 20 Sedimentation assay pellet 
 
  
Figure 20: Quantification of the fluorescence of the lipid gradient of 
sucrose-loaded LUVs after centrifugation.  A 500 µL sample of LUVs 
containing 5% dansyl-labeled PS was centrifuged at 150,000 x g for 
30 min.  Successive aliquots of the supernatant were removed and 
analyzed for fluorescence at 340:500-620 nm.  After removal of 
supernatant, 40 µL HNa100 was added to centrifuge tube and analyzed 
as pellet. 
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2.7.4.2 Nonspecific Interactions 
Nonspecific interactions between our protein and the walls of the polycarbonate 
centrifuge tubes caused a significant loss of protein, which was a concern since our 
experiments used protein concentrations of 40 nM to stay well below the Kd of binding.  
Nonspecific binding is thought to be due to the highly basic charge interaction with the 
acidic polycarbonate.  Without protection, the myo1c-tail would practically disappear, 
as assessed by SDS-PAGE gel. 
Two different strategies were combined to solve this problem.  All tubes were 
coated with a bath sonicated solution of 40 µM PC hydrated in HNa100.  This formed a 
thin film on the polycarbonate, which prevented myo1c from binding.  The addition of 
non-specific blocking proteins to the samples was also used to help resolve this issue.  
Three different proteins were tested; CaM, fibrinogen, and GST (Figure 21).  CaM 
showed no increase in recovery of myo1c from polycarbonate tubes; fibrinogen and 
GST both showed close to 100 % recovery.  We selected GST because of its low 
molecular weight and availability, and added 0.25 mg/mL to all centrifugation samples. 
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Figure 21 Nonspecific blockers 
 
  
Figure 21: Quantification of the recovery of myo1c-tail after sedimentation in 
the presence of proteins to block nonspecific interactions to the polycarbonate 
tubes.  CaM, Fibrinogen, or GST (5 mg/mL) were added to 40 nM myo1c-tail 
and centrifuged at 150,000 x g for 30 minutes.  Samples were analyzed for the 
percentage of myo1c-tail recovered from supernatant after centrifugation. 
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2.7.4.3 Sedimentation 
Protein binding to LUVs was determined by sedimentation assays conducted 
with 200 l samples in an ultracentrifuge with a TLA-100 rotor (Beckman).  
Polycarbonate centrifuge tubes were incubated for an hour in 50 μM solution of PC in 
HNa100.  GST (0.25 mg/ml) was added to every sample.  Sucrose-loaded LUVs were 
sedimented at 150,000 x g for 30 min at 25 C.  The top 160 L of each sample was 
removed and analyzed as supernatant.  We called the remaining 40 μL the “pellet,” 
although it contains approximately 20 % of the supernatant.  The pellets were re-
suspended with 10 L SDS-PAGE sample buffer and boiled for three minutes.  Bound 
proteins were resolved by SDS-PAGE and stained with SYPRO-red (Invitrogen) for 
quantization as described below.  A sample gel with standards is shown (Figure 22).  
Supernatants containing GFP-proteins were assayed for GFP fluorescence in a 
fluorimeter.  Gels were scanned using a gel scanner, and data were analyzed with 
MetaMorph (Universal Imaging). 
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Figure 22 Sedimentation assay 
  
Figure 22: A representative SYPRO red stained SDS-PAGE gel from a 
sedimentation assay.  Top)  Approximate scale representation of a 100 nm 
LUV and a full length myo1c binding.  Bottom) SYPRO-red stained SDS-
polyacrylamide gel of myo1c-tail from the pellets of a sedimentation assay 
with 0 - 400 M LUVs (total lipid) containing 2% PIP2.  The last 3 lanes are 
myo1c-tail standards used for normalization.  Bottom figure originally 
published in (Hokanson and Ostap 2006) 
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2.7.5 Gel Filtration 
Gel filtration allows for the separation of molecules based on hydrodynamic 
radius.  Columns are made up of beads with small pores that increase the run volume of 
smaller molecules, while proteins too large to fit in the pores flow by in a smaller run 
volume.  Therefore, a column containing beads with pore sizes that are relative in size 
to the hydrodynamic radii of the small molecules of interest can be used to test for the 
direct binding of these small molecules to larger proteins.  The population of small 
molecules bound to the larger proteins will elute much earlier than the population of 
free small molecules.  To separate free Ins(1,4,5)P3 from myo1c-tail bound Ins(1,4,5)P3, 
we initially tried Sephadex G-25 resin, but found that the myo1c-tail bound to the resin 
through presumably nonspecific interactions.  Therefore, we used ToyoPearl HW40F 
resin, which did not interact with myo1c-tail, but did retard the elution of free 
Ins(1,4,5)P3.   
Gel filtration assays were preformed as described (Lemmon, Ferguson et al. 
1995).  ToyoPearl HW40F resin (10 mL) was resuspended and packed into a 9 mm 
diameter column.  The gel filtration column was equilibrated with 10 column volumes 
HNa100; protein samples of 50 µL PLC-PH (10 μM) or 10 μM myolc-tail mixed with 
2-fold excess 
3
H-Ins(1,4,5,)P3 in HNa100 buffer were carefully loaded onto the top of 
the column bed without disturbing the resin. After the protein and Ins(1,4,5)P3 mixture 
was fully immersed into the column bed, HNa100 was added to the column in 3 x 100 
µL aliquots and then used to fill the column.  Fractions were collected every ~200 L 
starting as soon as the protein and Ins(1,4,5)P3 mixture was loaded onto the column.  
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The elution position of protein was determined by absorbance at 280 nm.  Scintillation 
counting was used to detect the 
3
H-Ins(1,4,5)P3 elution position by measuring the 
counts per minute of 50 µL of each fraction in 5 mL of scintillation fluid.   
 
2.7.6 Digestions 
Trypsin was used to do controlled digests of myo1c-tail at various 
concentrations and time points.  Trypsin and soybean inhibitor (SI) were made up to 5 
mg/mL stock solutions in HNa100.  Trypsin was added in 1:100 to 1:2000 ratios by 
weight to myo1c-tail plus or minus Ins(1,4,5)P3 and incubated for 0 to 40 minutes 
before each reaction was quenched with SI.  Samples were then run on an SDS-PAGE 
gel and imaged by Coomassie staining or by Western blot.  
 
2.7.7 Florescence Studies 
Florescence resonance energy transfer (FRET) is a fluorescence technique that 
measures the fluorescence resonance energy transfer of one fluorophore, a donor, to 
another fluorophore, an acceptor, when the two fluorophores are in close proximity to 
one another (Lankiewicz, Malicka et al. 1997).  LUVs containing both BODIPY FL-
PIP2 and BODIPY TMR-PIP2 were used to detect the clustering of PIP2 upon protein 
binding.  These fluorescent tags were chemically attached to the acyl chains of PIP2 and 
should not have affected the binding of proteins to the inositol head-group.  We excited 
our donor, fluorescein (FL), at 495 nm, which resulted in an emission spectrum that 
overlapped with the excitation spectrum of our acceptor, tetramethylrhodamine (TMR).  
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We measured the emission of any consequently excited TMR at 575 nm.  Emission and 
excitation spectra of the fluorophores are shown (Figure 23).  When the two 
fluorophores are close enough to each other, the emission of the donor fluorophore is 
transferred to the acceptor fluorophore.  A decrease in the fluorescence of the donor and 
an increase in the fluorescence of the acceptor were then seen as an increased number of 
fluorophores were clustered together.  Thus, the fluorescence ratio of FL/TMR 
decreased when the fluorescent PIP2 molecules were clustered together by the binding 
of a protein (Figure 24). 
LUVs with 0.4% BODIPY FL-PIP2 and 0.4% BODIPY TMR-PIP2 in a 
background of PC were titrated with 0 – 1 µM myo1c-tail or MARCKS peptide (a gift 
from Dr. Mark Lemmon).  FRET from FL to TMR was detected by exciting FL at 500 
nm and measuring TMR emission fluorescence at 575 nm. 
 
 
Figure 23 Excitation and emission spectra of FL and TMR 
 
 
 
  
Figure 23: The fluorescence excitation and emission scans of FL 
and TMR labeled PIP2.  FL excites at 505 nm and emits at 513 nm.  
TMR excites at 532 nm and emits at 574 nm. 
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Figure 24 FRET from clustering PIP2 
Figure 24: A schematic of FRET.  Upon excitation, yellow arrow, the 
donor molecule, FL, becomes excited and emits light, orange arrow. 
This emission either leaves the system (left) or is transferred to an 
acceptor molecule, TMR (right).  The latter is the case when the two 
fluorophores are near each other as depicted on the right by the 
presence of MARCKS. 
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2.8 Live Cell Imaging 
Cells were placed on 40-mm glass cover slips and mounted in a temperature-
controlled flow chamber (Bioptechs, Butler, PA) for microscopic observation and 
perfused with DMEM, 10 mM HEPES, and 10% FBS (Tang and Ostap 2001).  Cells 
were visualized through a 63x oil immersion objective with an inverted fluorescence 
microscope (Leica).  The temperature of the flow chamber and microscope objective 
was maintained at 37 °C throughout the experiment.  Images were acquired with a 
digital camera (Hamamatsu) and Metamorph software (Universal Imaging).  The 
fluorescence excitation light was shuttered (Sutter Instruments), and exposure times 
were between 0.1 and 1.0 s.  
 
2.8.1 TIRF/FRAP 
TIRF is a technique designed to reduce background fluorescence of a specimen 
by exciting fluorophores within 100 nm of the objective (Axelrod, Thompson et al. 
1983).  Evanescent waves that excite fluorophores are generated when an objective with 
a high numerical aperture is used to bring incident light in at an angle larger than the 
critical angle with respect to the surface, and is totally reflected at the glass-water 
interface.  The resulting evanescent electromagnetic field decays exponentially from the 
interface, and thus penetrates to a depth of approximately 100 nm into the sample 
medium.  This technique allowed us to look at events that occurred at and directly 
above the plasma membrane without the background fluorescence of the entire cytosol. 
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2.8.1.1 TIRF 
Objective-type total internal reflection fluorescence (TIRF) microscopy was 
performed on a modified Leica DMIRB microscope fitted with a Nikon 1.45 NA 
objective (Axelrod 2001).  Samples were illuminated through the rear port of the 
microscope with a 488 nm laser beam (Melles Griot) focused on the back focal plane of 
the objective.  Images were acquired with a digital camera (Hamamatsu) and 
Metamorph software (Universal Imaging).  A computer controlled filter wheel (Sutter 
Instruments) containing neutral density filters was placed in the beam path to allow for 
attenuation of the beam. 
 
2.8.1.2 FRAP 
We combined TIRF with fluorescence recovery after photobleaching (FRAP) to 
measure dissociation rates of membrane bound myo1c.  We were able to bleach either 
an entire cell or a ~ 10 µm spot on a cell expressing GFP-tagged constructs and 
measured the recovery of fluorescence over time.  The recovery of fluorescence was 
due to new, unbleached fluorophores replacing bleached fluorophores at either the 
membrane, or diffusing in the cytosol just above the membrane.  Since the association 
of myo1c to the membrane was measured to be diffusion limited (Tang, Lin et al. 2002), 
we were able to interpret the recovery of fluorescence as dissociation rates of bleached 
protein.  Photobleaching by TIRF illumination was accomplished by removing the 
neutral density filter and decreasing the beam diameter. 
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TIRF/FRAP was performed as follows.  Five prebleached TIRF images were 
acquired 5 - 10 s apart with a 100 ms acquisition time, followed by a 1 s bleaching 
TIRF pulse, followed by the immediate acquisition of images 1 - 2.5 s apart with 100 
ms acquisition time.  The bleach illumination was 10 - 100-fold more intense 
(depending on the cell intensity) than the imaging illumination. 
 
 
2.9 Data Analysis  
2.9.1 Binding Data Analysis 
To quantify the amount of protein in each lane from our sedimentation binding 
assays, the integrated intensity of each protein band on the scanned gels was subtracted 
from the integrated intensity of the region directly above the protein band to correct for 
variations in background.  Protein standards of known concentration were run on each 
gel to ensure that the intensity of the protein bands were within the linear range of the 
scanner and to translate integrated intensity to moles of bound protein (Figure 22).  We 
reported the binding affinity of myo1c protein constructs to LUVs as a molar partition 
coefficient in terms of total lipid concentration (Keff
lipid
) or in terms of the accessible 
acidic phospholipid concentration (Keff
acidic
).  The molar partition coefficient, K, is 
defined by:  
Equation 2 
[𝑃]𝑚
[𝐿]
= 𝐾[𝑃] 
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where [P]m is the molar concentration of the protein bound to the membrane, [P] is the 
free protein concentration, and [L] is the total lipid concentration (Peitzsch and 
McLaughlin 1993).  In our experiments [L] is in 1000-fold excess to [P]m so loss of [L] 
after binding does not need to be considered.  By defining [P]tot: 
Equation 3 
 𝑃 𝑡𝑜𝑡 =  𝑃 𝑚 +  𝑃  
binding curves can be fit to: 
Equation 4 
[𝑃]𝑚
[𝑃]𝑡𝑜𝑡
=
𝐾[𝐿]
1 + 𝐾[𝐿]
 
where K equals the concentration of lipid at which half of the protein binds and is given 
in M
-1
.  Binding data were fit to hyperbolae using KaleidaGraph. 
All data were normalized from integrated intensities to molar concentrations by 
fitting internal standards of known myo1c-tail concentration from each gel to a linear 
line.  Data was further normalized to percentage of myo1c-tail bound by: 
Equation 5 
%𝐵𝑜𝑢𝑛𝑑 =
[𝑀𝑥] − [𝑀0]
[𝑀𝑡] − [𝑀0]
 
where Mx is the concentration of myo1c-tail in the pellet in the presence of x lipid, M0 is 
the concentration of myo1c-tail in the pellet in the absence of lipid, and Mt is the 
concentration of myo1c-tail calculated if 100% of it was in the pellet. 
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Binding data plotted as a function of [NaCl] were fit to an abbreviated equation 
derived from Debye-Hückel theory that describes the change in dissociation constant 
with ionic strength by: 
Equation 6 
𝑙𝑜𝑔𝐾 =  𝑙𝑜𝑔𝐾0 −
2𝐴𝑧𝑅𝑧𝐿 𝐼
1 + 𝑟𝐵 𝐼
 
where logK is the log of the dissociation constant, A and B are thermodynamic constants 
equal to 0.509 and 2.391 nm
-1
 respectively, zR and zL are the charges on the receptor and 
ligand respectively, I is the ionic strength , and r is the effective interaction distance 
between receptor and ligand (Meltzer, Lurtz et al. 2006). Ionic strength is defined by:  
Equation 7 
𝐼 =  
1
2
 𝑚𝑖𝑧𝑖
2
𝑖
 
where m is the molar concentration of the ion, and z is the charge. 
 
2.9.2 Competition Data Analysis 
Soluble inositol phosphate competition data were fit to: 
Equation 8 
𝑓𝑏 =
[𝑃𝐼𝑃2 ]
𝐾𝑒𝑓𝑓
𝑎𝑐𝑖𝑑𝑖𝑐  1 +
 𝐼𝑛𝑠𝑃𝑥 
𝐾𝐼𝑛𝑠𝑃𝑥
 + [𝑃𝐼𝑃2]
 
where [PIP2] is the concentration of accessible PIP2, [InsPx] is the concentration of the 
soluble inositol phosphate, KInsPx is the affinity of the inositol phosphate for myo1c, and 
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Keff
acidic
 is the effective dissociation constant of the myo1c-PIP2 interaction in terms of 
accessible concentration of PIP2 (Kubala, Plasek et al. 2004). 
 
2.9.3 TIRF/FRAP Analysis 
For presentational purposes, the photobleached region of each cell was 
normalized by dividing the image by the same region acquired 20 – 30 s before the 
bleach pulse, and then multiplied by 1000 to allow visualization of a 12-bit image.  This 
normalization allows the fluorescence recovery to be visualized without the 
complication of cell intensity variation. 
For analysis, the average background intensity was subtracted from the image, 
and the integrated intensity of the bleached spot was normalized by dividing by the 
intensity before the bleach.  Thus, the intensity of the spot before the bleach is set to 
one, and absence of fluorescence is set to zero.  After the bleaching pulse, the 
illumination required for visualization of the recovery time-course resulted in further 
photobleaching (< 15%) in some cells.  This non-FRAP bleaching was corrected for by 
subtracting the rate of photobleaching as determined in an area away from the FRAP 
region.  The effective rate of fluorescence recovery was determined by fitting the 
recovery transient to the sum of two exponential rates using KaleidaGraph (Synergy 
Software). 
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2.10 Molecular Modeling and Structure Prediction  
2.10.1 Phyre Protein Fold Recognition Server 
We used the Phyre server (www.sbg.bio.ic.ac.uk/phyre/) to initially reveal the 
secondary structural similarities of the tail domain to a PH domain.  The Phyre server 
predicts the three-dimensional structure of a protein sequence by “threading” it through 
known structures and scoring it for compatibility (Kelley, MacCallum et al. 2000).  To 
identify potential structural homologs, we performed a BLAST search on the myo1c-tail 
sequence, identifying phosphatidylinositol-dependent protein kinase-1 (PDK1) as a 
limited sequence match.  Since PH domain of Pdk1 had been crystallized with 
Ins(1,3,4,5)P4 (PDB 1W1D) and our myo1c-tail sequence showed 61% identity over the 
PIP2 binding region of PDK1, we used this structure for a detailed structural 
comparison. 
 
2.10.2 Ab Initio Structural Prediction 
To provide further speculative structural insight into the binding of PIP2 by the 
myo1c- tail, we collaborated with Dr. Dave Sept (Washington University, St. Louis, 
MO) who ran the mouse myo1c sequence through Pfam to identify known domains 
(Bateman, Coin et al. 2004).  Based on the Pfam analysis, he selected a region 
following the IQ motif as the tail region (P802-R1028) and used this sequence in ab 
initio structure prediction with Rosetta (Bonneau, Strauss et al. 2002), generating a total 
of 50 structures.  Clustering the structural predictions based on root mean square 
deviation resulted in a top structural candidate, and the side-chains of this structure were 
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added in and minimized using PLOP (Jacobson, Pincus et al. 2004).   This completed 
structure was then simulated using molecular dynamics in Gromacs 3.3 (Lindahl 2001).  
The simulation used the OPLS/AA force field, TIP3P water, and periodic boundary 
conditions with Particle Mesh Ewald for long range electrostatics.  After heating the 
system in 50K steps and equilibrating for 1 ns, the structure was simulated for a total of 
20 ns at 300K.  There were some minimal structural rearrangements during the 
simulation, but the basic structure of the protein remained constant throughout the 
simulation.  Finally, to identify potential structural homologs, we performed a BLAST 
search on the myo1c-tail sequence, identifying phosphatidylinositol-dependent protein 
kinase-1 (PDK) as a limited sequence match.  Since PDK1 had been crystallized with 
Ins(1,3,4,5)P4 (PDB 1W1D) and our myo1c tail sequence showed 61% identity over the 
PIP2 binding region of PDK1, we used this structure for a detailed structural 
comparison. 
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3 Results 
 In this section, data will be presented from an investigation into the interactions 
of myo1c with the lipid membrane.  In this study, sedimentation assays were used to 
characterize the binding constants of myo1c for LUVs composed of various ratios of PS 
and PIP2, as well as inositol phosphates.  Constructs defined in chapter two were 
expressed in NRK cells to determine localization and in vivo activity.  These results 
reveal that myo1c binds tightly to PIP2 through a specific interaction in its tail domain. 
  
3.1 Mechanism for Membrane Binding 
To understand biochemically how myosin-Is interacted with the plasma 
membrane, we obtained steady state binding constants by performing a quantitative 
investigation under different parameters.  Sedimentation assays using LUVs were used 
as the primary experiment for quantitatively determining the interactions between 
myo1c and phospholipids.  This was an ideal system to use because it allowed us to do 
in vitro experiments with a fluid bilayer system that mimicked the phospholipid bilayer 
of the inner leaflet in the plasma membrane (Buser and McLaughlin 1998).  Through 
extrusion techniques, we were able to precisely control the radii of our LUVs to 50 nm, 
as verified by DLS.  This gave us a uniform binding substrate to work with, as well as 
accurate control over the molar ratios of various lipid contained within the vesicles.  All 
sedimentation assays were performed using LUVs with PC as the background 
phospholipid. 
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3.1.1 Myo1c-Tail Binds LUVs Containing High Levels of PS 
To determine if myo1c bound to lipid membranes containing PS, we tested the 
binding of a myo1c construct containing the 3 IQ motifs and tail domain (myo1c-tail) 
(Figure 11) to LUVs composed of 20% PS, 40% PS, 60% PS, and 80% PS in a PC 
background using our sedimentation assay as illustrated (Figure 25A).  Myo1c-tail, 40 
nM, was sedimented in the presence of 0 – 400 µM LUVs.  The pellets were run on an 
SDS-PAGE gel and analyzed for the amount of myo1c-tail present.  We plotted the 
percentage of myo1c-tail bound as a function of lipid concentration to determine the 
effective dissociation constants using Equation 4 and Equation 5, which were expressed 
in terms of total lipid (Keff
lipid
) or accessible acidic phospholipid (Keff
acidic
), for the 
interaction between myo1c-tail and LUVs containing varying amounts of PS in a 
background of PC.  We used a low concentration of myo1c-tail (40 nM) to ensure that 
we stayed below the effective dissociation constant of myo1c : lipid. 
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Figure 25 Total lipid vs.mol % binding assay 
  Figure 25A-B: A representation of the centrifuge tubes in the 
sedimentation assays.  Shown is a comparison between an increase in 
concentration and an increase in mol %. A) An increase in the 
concentration increases the number of LUVs, but keeps the density of 
PIP2 (blue dots) constant.  B) An increase in mole % increases the 
density of PIP2 within the LUVs, but keeps the number of LUVs 
constant. 
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We were unable to detect binding of myo1c-tail to LUVs containing only PC, or 
to LUVs containing physiological molar concentrations of PS ~20% (Figure 26).  
Myo1c-tail only bound to PS containing LUVs when the molar concentration of PS was 
increased to 60% or higher.  At these high, non-physiological concentrations of PS, 
myo1c-tail bound with Keff
lipid
 = 11 ± 2.0 µM (Keff
acidic
 = 3.2 ± 1.0 µM) to 60% PS 
LUVs, and with Keff
lipid
 = 4.1 ± 0.70 µM (Keff
acidic
 of 1.7 ± 0.060 µM) to 80% PS LUVs 
(Table 1).  These data confirmed previous studies showing that myosin-I bound to 
anionic lipids (Adams and Pollard 1989; Hayden, Wolenski et al. 1990), and that its 
binding was dependent on the molar concentration of PS (Tang, Lin et al. 2002); 
however, it also showed that the association could not solely be based on non-specific 
electrostatic interactions, as physiological levels of PS do not support binding.  
Therefore, we hypothesized that for myo1c to bind to the membrane, additional factors 
must be required. 
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Figure 26 Sedimentation assays 
 
  
Figure 26: The association of the myo1c-tail with LUVs.  Lipid concentration 
dependence of 40 nM myo1c-tail binding to LUVs composed of PC and () 0% 
PS, () 20% PS, () 40% PS, () 60% PS, () 80% PS, () 2% PIP2, and 
()20% PS + 2% PIP2.  Each point is the average of 2-6 measurements.  The 
solid and dashed curves are the best fits of the 2% PIP2 and 20% PS + 2% PIP2 
data to equation 2.4, respectively.   The Keff of each data set is listed Table 1. 
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Table 1 Effective dissociation constants for myo1c-tail binding to LUVs.
 a
 
 
LUV composition Keff
lipid (M)c Keff
acidic (M)d 
0% PS > 400 N.A. 
20% PS > 400 > 40 
40% PS > 400 > 80 
60% PS 11 ± 2.0 3.2 ± 1.0 
80% PS 4.1 ± 0.70 1.7 ± 0.060 
2% PIP2 
2% PIP2 + 20% PS 
23 ± 5.0 
± 1.5 
0.23 ± 0.050 
0.44 ± 0.17 
a10 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM EGTA, 1 mM DTT, 1 μM CaM 
bThe mole percentages PS and PIP2 are reported with the remainder composed of PC. 
cEffective dissociation constants expressed in terms of total phospholipid.  Errors are 
standard errors of the fit. 
dEffective dissociation constants expressed in terms of accessible acidic phospholipid.  
Errors are standard errors of the fit. 
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3.1.2 Myo1c-Tail Binds LUVs Containing Low Levels of PIP2 
We next studied binding interactions between myo1c and LUVs containing a 
highly regulated and essential signaling phospholipid, PIP2, using our sedimentation 
assay.  Although the physiological concentrations of PIP2 in the inner membrane are 
only 1 - 2 % (as compared to 20 - 30% for PS) (Verkleij, Zwaal et al. 1973), it has three 
to four times the effective negative charge as PS and has been shown to bind 
specifically to many membrane associated proteins (DiNitto, Cronin et al. 2003).  
Myo1c-tail, 40 nM, was sedimented in the presence of 0 – 400 µM 2% PIP2 LUVs.  
Myo1c-tail bound to 2% PIP2 LUVs in a PC background with Keff
lipid
 = 23 ± 50 µM 
(Keff
acidic
 = 0.23 ± 0.050 µM) (Figure 26, Table 1).  These data confirmed that the 
interaction between myo1c and the plasma membrane could not be entirely electrostatic, 
as myo1c bound tightly to LUVs composed of 2% PIP2 and not to LUVs comprised of 
40% PS, which contained five to seven times the effective charge.  Myo1c-tail clearly 
showed a binding specificity to LUVs containing PIP2 over those containing PS. 
 We determined the affinity of myo1c-tail for 2% PIP2 + 20% PS LUVs to be 
Keff
lipid
 = 4.0 ± 1.5 µM (Keff
acidic
 = 0.44 ± 0.17 µM) (Figure 26, Table 1).  While the 
affinity for accessible lipid was two-fold lower, the affinity for total lipid (which is 
more relevant to membrane binding) was roughly six times greater than to LUVs of just 
2% PIP2 alone.  Therefore, although myo1c-tail did not bind to 20% PS alone, PS 
appeared to demonstrate an additive effect when in the presence of 2% PIP2. 
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3.1.3 Myo1c Membrane Binding is Salt Sensitive 
To test if the binding of myo1c-tail to LUVs composed of PS or PIP2 has an 
electrostatic component, we measured the binding as a function of the amount of NaCl 
in solution.  Binding data were fit to Equation 6, an abbreviated equation derived from 
Debye-Hückel theory (Meltzer, Lurtz et al. 2006) that relates the change of dissociation 
constants to the changes of ionic strength.   
Myo1c-tail, 40 nM, and 60 µM LUVs were sedimented in the presence of 0 – 1 
M NaCl.  We found that the interaction of myo1c-tail to 2% PIP2 LUVs had a slightly 
higher dependence on the ionic strength of the solution than with 60% PS LUVs (Figure 
27A).  A fit of the data to Equation 6 yielded net charges of -4.7 and -1.6 with 
interaction distances of 0.43 and 0.12 nm for 60% PS and 2% PIP2 respectively (Figure 
27B).  Considering that PIP2 has a net charge of -4 at pH 7.0, if we assumed 1:1 binding 
between myo1c and PIP2, the effective charge for the region of myo1c-tail that interacts 
with PIP2 would be 0.39, while the region that interacts with PS, charge of -1, would be 
4.7.  This implied that if the same region of myo1c-tail interacts with both PIP2 and PS, 
up to 12 molecules of PS could be required for tight binding. 
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Figure 27 Salt dependence and Debye Hückel 
  
Figure 27A-B: The effect 
of ionic strength on 
myo1c-tail binding to 
LUVs.  A) Dissociation 
of 40 nM myo1c-tail 
from 60 µM 60% PS () 
or 2% PIP2 () LUVs as 
a dependence of NaCl 
concentration.  B)  The 
same data plotted as the 
log of the Kd as a 
function of the square-
root of the ionic strength.  
The solid and dashed 
curves are the best fits of 
the 2% PIP2 and 60% PS 
data to Equation 6, 
respectively. 
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3.1.4 Myo1c Does Not Cluster PIP2 
Some PIP2 binding proteins, such as MARCKS, have been shown to cluster 
multiple PIP2 molecules within close proximity to increase the density of anionic 
charges (Gambhir, Hangyas-Mihalyne et al. 2004).  We used FRET to determine if 
myo1c was able to cluster PIP2 labeled at the ends of one of its acyl chains with a donor 
fluorophore, FL, and PIP2 labeled at the ends of one of its acyl chains with an acceptor 
fluorophore, TMR, on LUVs.   
We measured the steady state fluorescence signal from FRET for both 0 – 5 µM 
MARCKS peptide and 0 – 10 µM myo1c-tail bound to 200 or 250 µM LUVs containing 
0.8% of fluorescently labeled PIP2 and plotted the ratios of TMR/FL emission spectra as 
a function or protein concentration.  We observed no change in the FRET ratio with the 
addition of up to 1 µM myo1c-tail (Figure 28A), but saw a significant decrease in the 
FRET ratio with the addition of MARCKS peptide that appeared to saturate at around 
10 µM (Figure 28B).  This was due to a significant decrease in emission of FL at 514.5 
nm, but little increase in the emission of TMR at 572.5 nm (Figure 28C).  As a control, 
we confirmed that myo1c-tail was able to bind to LUVs containing 0.8% fluorescently 
labeled PIP2 by using our standard binding assay.  Although we did not observe a true 
FRET signal between our fluorescently labeled PIP2 with the addition of MARCKS, the 
decrease of TMR fluorscence suggests that MARCKS affected the lateral distribution of 
PIP2 in LUVs, whereas myo1c-tail did not.   
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Figure 28 Myo1c and MARCKS FRET 
  
Figure 28A-C: FRET ratios from 
PIP2 clustering.  LUVs containing 
0.5% (), 0.8% (), or 1.2% () 
FL and TMR labeled PIP2 were 
incubated with increasing 
concentrations of A) myo1c-tail, 
or B) MARCKS peptide.  The 
ratio of TMR fluorescence 
measured at 514.5 nm over FL 
fluorescence measured at 572.5 
nm is plotted as a function of 
protein.  C) Raw fluorescence 
spectra of FL and TMR emissions 
with increasing concentrations of 
MARCKS. 
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3.1.5 Cooperative Binding of PIP2 
Membrane association of certain PIP2 binding proteins, e.g. MARCKS 
(McLaughlin, Wang et al. 2002) and N-WASP (Papayannopoulos, Co et al. 2005), 
requires cooperative binding.  A minimum negative density threshold must exist before 
binding occurs, which results in a sigmoidal binding curve (Figure 29A).  This is in 
contrast to proteins that bind to PIP2 directly and do not require multiple PIP2 molecules 
to bind.  Examples of this are PPB PH domain containing proteins, which have a 
hyperbolic binding curve (Figure 29B).   
 
Figure 29 Cooperative binding curves 
Figure 29A-B: Figures are taken 
from (Papayannopoulos, Co et al. 
2005).  Binding isotherms for A) N-
WASP, and B) PLCδ-PH were 
measured with a fluorescence 
perturbation assay from.  A) 
Cooperative binding requiring a 
minimal density of PIP2 before 
binding occurs.  Note the lag phase 
from 0 – 2 Mol% PIP2.  B) Direct 
binding to the head group of PIP2 
does not require a minimum density 
of PIP2. 
A 
B 
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To determine if myo1c bound PIP2 in a cooperative manner, we measured 40 
nM myo1c-tail binding to increasing molar concentrations of PIP2 while maintaining 
the same total lipid concentration at either 30 or 60 µM (Figure 25B).  The resulting 
binding curve of myo1c-tail bound as a function of increasing molar concentrations of 
PIP2 had a hyperbolic dependence (Figure 30), signifying that the binding was not 
cooperative; if binding was cooperative, then we would have expected to see a 
sigmoidal binding curve with a lag-phase at low molar concentrations of PIP2.  
Moreover, when we plotted the percentage of myo1c-tail bound from our previous 2% 
PIP2 binding experiments at varying lipid concentrations as a function of the 
concentration of accessible PIP2 (Figure 30 inset), we found the concentration 
dependence of binding to be nearly identical.  This mode of binding supported our 
previous conclusions from our stoichiometric data, suggesting that the binding ratio of 
myo1c to PIP2 is 1:1. 
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Figure 30: Figure was originally published in (Hokanson and Ostap 2006).  Binding 
of 40 nM myo1c-tail to 30 µM LUVs (total lipid) composed of 0 – 10% PIP2.  The 
percent of membrane-bound myo1c-tail is plotted as a function of the percentage of 
PIP2 in the LUVs, rather than total lipid concentration.  Each point is the average of 
three measurements.  (Inset) The same data plotted as a function of the accessible 
PIP2 concentration (○).  Data in the inset also include the percent of 40 nM myo1c-
tail bound to () 60 M LUVs containing 0 - 5% PIP2 and (●) 0 – 400 µM LUVs 
containing 2% PIP2 from Figure 22.   
Figure 30 Myo1c binding as a function of mol% PIP2 
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3.1.6 Calcium and CaM Myo1c-Tail Binding 2% PIP2 LUVs 
It had been proposed that the lipid binding site of myo1c was located in the 
regulatory domain and not in the tail domain (Swanljung-Collins and Collins 1992; 
Tang, Lin et al. 2002; Hirono, Denis et al. 2004).  This model suggested that lipid 
binding required Ca
2+
-dependent conformational changes in one or more CaM bound to 
the three IQ motifs in the regulatory domain.  This conformational change or 
dissociation of CaM from an IQ motif was proposed to have the potential to expose 
basic polypeptide stretches that might be responsible for binding to anionic lipids 
(Figure 31).  In order to test this model, we measured the effects of both Ca
2+
 and CaM 
on the steady-state binding of myo1c-tail to LUVs composed of 2% PIP2 or 20% PS. 
 
Figure 31 Ca
2+
 regulation of CaM reveals lipid binding site 
   Figure 31: A cartoon showing a proposed effect of Ca
2+
 revealing a 
lipid binding site.  High levels of Ca
2+
 change the conformation and 
cause at least one bound CaM (blue bars) to dissociate.  This reveals 
a basically charged IQ motif which could interact with acidic lipids 
shown in red. 
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Myo1c-tail, 40 nM, was sedimented in the presence of 0 – 200 µM LUVs with 
or without 10 µM free Ca
2+
, or 40 nM myo1c-tail was sedimented with 60 µM LUVs in 
the presence of 0 – 100 µM CaM.  We determined that the interaction of myo1c-tail and 
LUVs was neither inhibited by the addition of up to 100 µM CaM (Figure 32A), nor 
was there a significant increase in affinity in the presence of 10 µM free Ca
2+
 (Figure 
32B).  We concluded that the binding of myo1c-tail to 2% PIP2 LUVs was not affected 
by an increase in Ca
2+
 levels and was not dependent on the conformational changes of 
CaM bound to the IQ motifs. 
 
Figure 32 CaM and Ca
2+
 dependence of myo1c-tail binding to PIP2 
Figure 32A-B: Figures were 
originally published in (Hokanson 
and Ostap 2006).  (A)  40 nM 
myo1c-tail binding to 60 M LUVs 
containing (●) 2% PIP2 or (▲) 60% 
PS LUVs in the presence of 0-100 
M calmodulin.  Each point is the 
average of two measurements.  (B)  
40 nM myo1c-tail binding to 0 - 400 
µM LUVs containing 2% PIP2 in the 
(●) absence and (○) presence of 10 
µM free calcium.  The solid line is 
the best fit to a rectangular 
hyperbola.  Error bars represent ± 1 
standard deviation (n = 4-6). 
97 
 
 
3.1.7 Regulatory Domain Binds to PS with a Calcium Dependence 
To further test if there were any contributions from the regulatory domain of 
myo1c for lipid binding, we ascertained the affinity of a myo1c construct containing the 
motor domain followed by the 3 IQ motifs (myo1c-motor) (Figure 11) for LUVs.  This 
construct was designed to lack the tail domain so that the only possible lipid binding 
site would be the motor or regulatory domains.  We tested the binding of 40 nM myo1c-
motor to 0 – 200 µM LUVs composed of 20% PS, 40% PS, 60% PS, 80% PS, 2% PIP2, 
and both 20% PS + 2% PIP2 all in a PC background, in the absence and presence of 10 
µM free Ca
2+
 using our sedimentation assays (Figure 33).  In the absence of Ca
2+
, 
myo1c-motor bound weakly to 40% PS LUVs (99 ± 24 µM), whereas 60% PS and 80% 
PS LUVs bound with affinities of 37 ± 5.6 µM and 23 ± 3.3 µM respectively (Table 2).   
In the presence of 10 µM free Ca
2+
, the affinity of myo1c-motor for ≥ 40% PS LUVs 
increased ~10-fold to as high as 0.42 ± 0.27 µM for 80% PS LUVs; this was consistent 
with the proposal that positive charges in the IQ motif were revealed upon Ca
2+
-induced 
dissociation of CaM. 
Physiological levels of PS in biological membranes are ~ 20% - 30% PS, so it is 
unlikely that myo1c binding to high PS concentrations is physiologically relevant.  
However, it is possible that additional factors in the cell could cause PS to cluster and 
form micro-domains (Murray, Arbuzova et al. 1999).  Given that our data showed a  
six-fold increase in affinity of myo1c-tail for 20% PS + 2% PIP2 LUVs over that of 2% 
PIP2 LUVs (Table 3.1), it was more likely that low concentrations of PS contributed to 
the binding energy when myo1c was attached to the membrane via 
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phosphatidylinositols.  Therefore, we concluded that it was the tail domain of myo1c 
that was responsible for localization and binding to the membrane.  Although the 
regulatory domain may have stabilized this interaction in a Ca
2+
 regulated manner once 
myo1c was already bound to the membrane through PIP2, it was not sufficient for 
membrane binding alone.  
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Figure 33 Myo1c-motor binding is Ca
2+
 dependent 
 
  
Figure 33:  Figure was originally published in (Hokanson, Laakso et al. 2006).  
Lipid concentration dependence of 40 nM myo1c-motor binding to LUVs 
composed of PC and 20% PS, 40% PS, 60% PS, 80% PS, 2% PIP2, and 20% PS + 
2% PIP2 in the () absence and () presence of 10 µM free calcium.  Each point 
is the average of 2 - 6 measurements.  The solid and dashed curves are the best fits 
of the data to hyperbolae. The Keff
lipid
 of each data set is listed in Table 2. 
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  Table 2 Effective dissociation constants for myo1c-motor binding to LUVs.
 a
 
 
LUV Compositionb Keff
lipid (M)c Keff
lipid (M)c 
 - Ca2+ + Ca2+ 
20% PS > 400 > 400 
40% PS 99 ± 24 11 ± 1.5 
60% PS 37 ± 5.6 3.2 ± 0.83 
80% PS 23 ± 3.3 0.42 ± 0.27 
2% PIP2 > 400 > 400 
2% PIP2 + 20% PS > 400 > 400 
a10 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM EGTA, 1 mM DTT, 1 μM CaM 
bThe mole percentages PS and PIP2 are reported with the remaining lipid composed of PC. 
cEffective dissociation constants expressed in terms of total phospholipid.  Errors are 
standard errors of the fit. 
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3.2 Inositol Phosphate Binding and Inhibition Studies 
In cells, many phosphatidyl inositols are hydrolyzed to form DAG and a soluble 
inositol phosphate by phospholipases (Figure 7).  It was important for us to determine if 
myo1c was able to bind to the soluble head groups of phosphatidyl inositols.  Polybasic 
proteins, e.g. MARCKS and N-WASP, are unable to bind soluble phosphatidyl inositol 
derivatives because they are not accessible in a multivalent manner like PIP2 in the 
membrane (Papayannopoulos, Co et al. 2005).  Phosphatidyl inositol binding proteins 
that have a specific interaction with the inositol head group bind to the phosphorylated 
inositol ring directly through an electrostatic association with the charged phosphates.  
The most studied is PLCδ-PH, which binds to Ins(1,4,5)P3 as well as PIP2 (Lemmon, 
Ferguson et al. 1995).  Determining whether myo1c bound directly to the inositol ring 
would give insight into the mechanism of binding.  
A secondary reason for determining if myo1c directly bound to inositol 
phosphates was the ability to test for inositol phosphorylation stereospecificity.  Many 
relevant phosphatidylinositols were not available from biochemistry reagent suppliers, 
and those that were did not easily go into solution and/or did not contain long acyl 
chains that would ensure their incorporation into LUVs.  A variety of soluble inositol 
phosphates were readily available from biochemistry reagent suppliers.   
By using competitive inhibition binding studies, we were able to measure the Kd 
of myo1c-tail for a variety of inositol phosphates.  We assumed that the myo1c-tail 
binds PIP2 with a 1:1 stoichiometry and that myo1c-tail has an affinity of Keff
acidic
 = 0.23 
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µM for PIP2.  Data was fit to Equation 8 to calculate binding affinities of inositol 
phosphates that bound to the PIP2 binding site of myo1c-tail and displaced it from the 
LUVs.  This fit also enabled us to determine the affinity for PIP2 of proteins that 
displaced myo1c-tail from the LUVs by binding to PIP2. 
 
3.2.1 Myo1c and PLCδ-PH Domain Compete for PIP2 Binding 
To determine if myo1c-tail bound to the same site on PIP2 as the canonical PIP2 
binding protein, PLCδ-PH, we tested if PLCδ-PH could competitively bind PIP2 
containing LUVs in the presence of myo1c-tail.  Myo1c-tail, 100 nM, was sedimented 
in the presence of 60 µM 2% PIP2 LUVs and 0-10 µM PLCδ-PH (Figure 34).  We 
found that PLCδ-PH was able to effectively displace the myo1c-tail from the LUVs in a 
dose dependent manner.  We calculated an effective dissociation constant for PLC-PH 
binding to PIP2 of Keff = 0.30 ± 0.030 M, which was in close agreement with 
previously determined values (Lemmon, Ferguson et al. 1995). 
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Figure 34: Figure was originally published in  (Hokanson and Ostap 2006).  Binding 
of 100 nM myo1c-tail to 60 µM LUVs containing 2% PIP2 in the presence of 0 – 10 
µM PLC-PH.  The inset is a SYPRO-red stained SDS-PAGE gel showing LUV-
bound (top) myo1c-tail and (bottom) PLCδ-PH as a function of total PLCδ-PH 
concentration. 
 
Figure 34 Myo1c and PLCδ-PH compete for PIP2 
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3.2.2 Myo1c Binds Directly to Ins(1,4,5)P3 
To ascertain whether myo1c-tail bound to the head group of PIP2 directly, we measured 
its ability to bind [
3
H]-labeled Ins(1,4,5)P3 by gel filtration chromatography (Figure 
35A-C).  We used PLC-PH as a positive control because it had previously been shown 
to bind tightly to Ins(1,4,5)P3 (Lemmon, Ferguson et al. 1995).  Both PLC-PH and 
myo1c-tail eluted as single peaks from gel filtration columns.  When PLC-PH and 
myo1c-tail were run with two-fold molar excess [
3
H]-Ins(1,4,5)P3,  [
3
H]-Ins(1,4,5)P3 
eluted as two peaks, one co-eluting with the PLC-PH or myo1c-tail, demonstrating a 
stable interaction, and the other corresponding to free [
3
H]-Ins(1,4,5)P3.   As a negative 
control, [
3
H]-Ins(1,4,5)P3 eluted as a single, non-protein-bound peak when run on the 
gel filtration column with GST, a protein that does not bind Ins(1,4,5)P3.  The elution 
position of protein was determined by absorbance at 280 nm.  Scintillation counting was 
used to detect the 
3
H-Ins(1,4,5)P3 elution position.  These results suggest that myo1c 
bound to Ins(1,4,5)P3 directly. 
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Figure 35 Gel filtration assay 
Figure 35A-C: Figures were 
originally published in 
(Hokanson and Ostap 2006).  
Myo1c-tail binds InsP3.  Gel 
filtration elution profiles of 
samples containing (A) 10 µM 
PLC-PH, (B) 10 µM myo1c-
tail, or (C) 10µM GST in the 
presence of excess 
3
H-
Ins(1,4,5)P3. The concentrations 
of InsP3 (solid lines) and PLC-
PH or myo1c-tail (dotted lines) 
are shown.  InsP3 run in the 
absence of protein in a separate 
experiment is also shown 
(dashed line) as a reference 
elution profile.  
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3.2.3 Myo1c Binds Inositol Phosphates Promiscuously 
To determine if myo1c binds to additional inositol phosphates, we tested the 
affinity of myo1c-tail for nine inositol phosphates by competitive binding.  We 
measured the ability of Ins(3)P1, Ins(1,3,4)P3, Ins(1,4,5)P3, Ins(1,2,6)P3, Ins(1,3,4,5)P4, 
Ins(1,2,5,6)P4, Ins(1,3,4,6)P4, Ins(1,2,3,5,6)P5, and InsP6 to compete with 2% PIP2 
LUVs for binding to myo1c-tail (Figure 36).   
Inositol phosphates (0 – 50 μM) were mixed with 50 nM myo1c-tail and 60 µM 
2% PIP2 LUVs.  At these concentrations, ~ 80% myo1c-tail was bound to the LUVs in 
the absence of inhibitor.  Eight of the nine inositol phosphates, when fit to Equation 4, 
gave results within a factor of three ranging from 96 ± 32 nM for Ins(1,4,5)P3 to 33 ± 7 
nM for Ins(1,3,4,5)P4.  The one exception that we obsevered was Ins(1,2,6)P3, which 
had a 10-fold lower affinity of 630 ± 130 nM (Table 3).  These affinities were over 2-
fold tighter binding than our measured affinity of myo1c-tail for PIP2 (K
eff
acidic = 0.23 ± 
0.050 µM), which suggested that Ins(1,4,5)P3 may be able to effectively displace myo1c 
from the plasma membrane in the cell; however, additional binding energies contributed 
by PS binding may prevent this from occurring.  The mono-inositol phosphate, Ins(3)P1, 
failed to inhibit the interaction of  myo1c with PIP2 at concentrations up to 100 µM.  
These results suggested that the binding of myo1c-tail to phosphatidyl inositols is not 
solely dependent on the number of charges, but also on the positions of the charges.  
Moreover, myo1c may have some inositol phosphate binding specificity for phosphates 
at the 4 and 5 positions of the inositol ring, as the affinity of myo1c for Ins(1,2,6)P3 is 
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10-fold weaker than all other inositol phosphates that contain a phosphate at one or both 
of these ring positions. 
 
 
Figure 36 InsPx competitive binding assay (PIP2) 
 
  
Figure 36: Figure was originally published in (Hokanson, Laakso et al. 2006).  
Binding of 40 - 100 nM myo1c-tail to 60 µM LUVs containing 2% PIP2 in the 
presence of 0 – 50 µM () Ins(1,4,5)P3, () Ins(1,3,4)P3, () Ins(1,2,6)P3, () 
Ins(1,3,4,5)P4, () Ins(1,2,5,6)P4, () Ins(1,3,4,6)P4, () Ins(1,2,3,5,6)P5 and 
() InsP6 (n for each point = 4 - 14).  Solid lines are fits to the () Ins(1,3,4,5)P4 
and () Ins(1,2,6)P3 using Equation 4.  Points at 0 µM InsPx are not shown due 
to logarithmic scale.  The effective dissociation constants obtained from the fits 
are listed in Table 3.   
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Table 3 Effective dissociation constants for inositol phosphates binding to myo1c-tail.
a
 
 
Inositol Phosphateb Kd
c 
Ins(3)P1 > 1 µM 
Ins(1,4,5)P3 96 ± 32 nM 
Ins(1,3,4)P3 61 ± 25 nM 
Ins(1,2,6)P3 630 ± 130 nM 
Ins(1,3,4,5)P4 33 ± 7.0 nM 
Ins(1,2,5,6)P4 53 ± 23 nM 
Ins(1,3,4,6)P4 67 ± 17 nM 
Ins(1,2,3,5,6)P5
 44 ± 14 nM 
InsP6
 48 ± 16 nM 
a10 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM EGTA, 1 mM DTT, 1 μM CaM 
bThe mole percentages PS and PIP2 are reported with the remaining lipid composed of PC. 
cEffective dissociation constants were determined by competition assays as described in 
Materials and Methods.  Errors are standard errors of the fit. 
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3.2.4 Ins(1,4,5)P3 Competes Weakly with Myo1c-Tail for PS Binding 
We hypothesized that if the binding of myo1c to PS was due to a separate 
binding site than that for PIP2, Ins(1,4,5)P3 should not be able to inhibit binding of 
myo1c-tail to LUVs comprised of PS.  We repeated our Ins(1,4,5)P3 competition 
binding studies using 50 nM myo1c-tail bound to 60 µM LUVs composed of 2% PIP2 + 
20% PS, 2% PIP2 + 60% PS, 20% PS, 60% PS, and 80% PS (Figure 37).  Only weak 
inhibition was seen with up to 50 µM Ins(1,4,5)P3 as most of the myo1c-tail remained 
bound to LUVs comprised of 2% PIP2 + 20% PS or 2% PIP2 + 60% PS.  Myo1c-tail 
also remained mostly bound to LUVs of 60% and 80% PS with Ins(1,4,5)P3 
concentrations up to 50 µM.   
We interpreted this data to signify that myo1c contained two separate binding 
sites.  One site bound tightly and specifically to phosphatidyl inositols in a 1:1 ratio and 
could be inhibited by inositol phosphates; a second site bound to PS or anionic lipids in 
a Ca
2+
 dependent manner and was not inhibited by inositol phosphates.  When both sites 
were bound to their respective substrates, i.e. LUVs with 2% PIP2 + 20% PS, binding 
was six-fold tighter (Table 1) and myo1c was not displaced from the LUVs by 
Ins(1,4,5)P3. 
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Figure 37 Ins(1,4,5)P3 competitive binding assay 
 
  
Figure 37: Binding of 50 nM myo1c-tail to 60 µM LUVs composed of (, 
solid line) 2% PIP2, ( uneven dashed line) 2% PIP2 + 20% PS, (, thin 
dashed line) 2% PIP2 + 60% PS, (, lowest dashed line) 20% PS, (, 
dotted line) 60% PS, and (, long dashed line) 80% PS (n for each point = 
4 - 14).  Lines are fits to the using the Equation 4.  Points at 0 µM InsPx are 
not shown due to logarithmic scale. 
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3.2.5 Ins(1,4,5)P3 Protects Myo1c-Tail from Trypsin Digest 
We found that Ins(1,4,5)P3 protects myo1c-tail from trypsin digestion while 
attempting to obtain a small, stable construct of the lipid binding domain of myo1c.  
100 µL aliquots of 0.3 mg/mL myo1c-tail were incubated with trypsin concentrations 
ranging from 0.15 - 3.0 µg/mL trypsin over 0 - 40 minutes before the reaction was 
quenched by the addition of equal amounts by weight of soybean inhibitor (SI).  
Myo1c-tail fragments were detected by Western blot and SYPRO red analysis (Figure 
38A-B).  A 1:1000 ratio by weight of trypsin to myo1c-tail for 40 minutes, or a 1:100 
ratio by weight of trypsin to myo1c-tail for 10 minutes effectively digested the myo1c-
tail to near completion.  Digestion fragments from a 1:1000 ratio by weight of trypsin to 
myo1c-tail can be clearly seen in the SYPRO red stained gel after 5 minutes (Figure 
38B).  A 1:100 ratio by weight of trypsin to myo1c-tail sample with 10 µM Ins(1,4,5)P3 
was not digested after 10 minutes, whereas a sample with no Ins(1,4,5)P3 was almost 
fully digested.  Similar results have shown that myo1a is protected by lipid vesicles 
when digested with α-chymotrypsin (Hayden, Wolenski et al. 1990).  We conclude from 
this finding that Ins(1,4,5)P3 helped to protect myo1c-tail from trypsin digestion, 
possibly by stabilizing a folded conformation or blocking one or more cleavage sites. 
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Figure 38 Myo1c-tail digest 
  Figure 38A-B: Western blot and SYPRO red stained SDS-PAGE gel of a myo1c-
tail trypsin digest.  A)  Digestion times were 5, 10, 20, 40 minutes at three 
dilutions.  Lanes 1 – 4 1:100 trypsin by weight, lanes 5 – 8 1:500 trypsin by weight, 
lanes 9 – 12 1:1000 trypsin by weight.  B) Digestion times were 0, 5, 10 minutes at 
three dilutions.  Lanes 1 – 3 1:1000 trypsin by weight, lanes 4 – 6 1:2000 trypsin by 
weight, lanes 7 - 9 1:100 trypsin by weight in the presence of 10 µM Ins(1,4,5)P3.
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3.3 In Vivo Localization Studies 
 We sought to show that the localization of myo1c in mammalian cells was 
consistent with the data from our in vitro binding assays.  To test this, we expressed a 
myo1c-tail construct with a GFP-tag at the N-terminus in mammalian cells.  We found 
that when a GFP-myo1c-tail chimera was expressed, it localized to the plasma 
membrane as shown previously (Figure 39) (Ruppert, Godel et al. 1995; Bose, 
Guilherme et al. 2002).  We further used this construct to show that myo1c concentrated 
on cellular PIP2 containing structures.  All of our constructs expressed in various cell 
types showed no dominant inhibitory effects to any of the cell processes we checked for 
including ruffling, lamellipodia retraction, filopodia, presence of vesicles, cell size, or 
mitosis (Figure 40).   
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Figure 39 Myo1c-tail localization 
  
  Figure 39: The localization of myo1c-tail by epifluorescence.  Four 
different cell types, A) NRK, B) CHO, C) COS-7, and D) HeLa, were 
transfected with GFP-tail and observed under epifluorescence.  Note the 
punctuate staining and membrane localization in each cell type. 
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Figure 40 No dominant negative effect 
  
Figure 40: Epifluorescence of CHO cells transfected with GFP-tail.  
Top images show fluorescence of actin labeled with rho-phalloidin.  
Bottom images show fluorescence of GFP-tail.  The focal plane of 
images on left are focused at the top of the cells to observe 
filopodia, the focal plane of images on the right are focused at the 
edges of the cell. 
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3.3.1 Ionomycin Redistributes Myo1c-Tail to the Cytoplasm 
PLC hydrolyzes PIP2 into two second messengers, DAG, which is retained in 
the membrane, and Ins(1,4,5)P3, which is soluble and contains the phosphorylated 
inositol ring.  We hypothesized that the tail domain of myo1c should localize to the 
plasma membrane and translocate to the cytoplasm upon calcium activation of PLC if it 
binds tightly to cellular PIP2 (Ryu, Suh et al. 1987).  To observe changes in localization 
of myo1c after Ca
2+
-induced activation of PLC, we added CaCl2 and ionomycin, an 
ionophore which allows Ca
2+
 to cross the plasma membrane.   
The addition of 10 μM ionomycin and 1.2 mM CaCl2 to the growth medium of 
NRK cells expressing GFP-myo1c-tail resulted in the redistribution of GFP-myo1c-tail 
to the cytoplasm (Figure 41).  The GFP-myo1c-tail reassociated with the plasma 
membrane upon washing out the CaCl2 and ionomycin.  In consideration of this result, 
we kept in mind that increased levels of Ca
2+
 in the cell from the addition of ionomycin 
can affect other factors in addition to activating PLC, all of which could potentially 
have inhibited myo1c localization.  The two most obvious possibilities we considered 
were the activation of scramblases, which flip PS molecules to the outside of the cell 
and deplete their effective concentration on the inner-leaflet, and electrostatic shielding 
at the plasma membrane.  Although this assay was relatively non-specific, it supported 
our findings that the myo1c-tail bound to PIP2 and that calcium did not increase the 
affinity of myo1c for the plasma membrane. 
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Figure 41 Ionomycin redistributes myo1c-tail 
 
 
 
 
3.3.2 Myo1c Found on Cellular PIP2-Containing Structures 
In addition to localizing to the plasma membrane, myo1c was found on cellular 
structures known to be enriched in phosphatidyl inositols.  In NRK cells undergoing 
macropinocytosis, we found that GFP-myo1c-tail transiently concentrated on the 
membrane during the early phases of membrane internalization (Figure 42).  Once the 
Figure 41: Figure was originally published in (Hokanson and Ostap 2006).  
Cellular distribution of GFP-tail during influx of calcium.  Fluorescence 
micrographs of a transfected NRK cell showing GFP fluorescence before, 
during, and after incubation with 10 μM ionomycin in medium containing 
1.2 mM CaCl2.  Scale bar is 15 μm.  
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macropinosome separated from the plasma membrane, the GFP-myo1c-tail dissociated 
from the membrane.  This transient localization closely mirrored the localization of 
PIP2-specific PH domains during macropinocytosis and phagocytosis (Cullen, Cozier et 
al. 2001; Simonsen, Wurmser et al. 2001), again supporting the proposal that myo1c 
primarily bound to cellular PIP2. 
 
Figure 42 Macropinocytosis event 
 
  
Figure 42: Figure was originally published in (Hokanson and Ostap 2006).  
Cellular distribution of GFP-tail during macropinocytosis.  Fluorescence 
micrographs of a transfected NRK cell showing GFP fluorescence around a newly 
internalized macropinosome (arrow).  Note the loss of fluorescence around 
macropinosome after it is internalized.  The time stamp is min:sec, and the scale 
bar is 5 μm. 
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3.4 Identifying the PIP2 Binding Site 
 Finding sequence homology to a PIP2 binding domain proved to be quite 
difficult, as there was no structural information known and very little sequence 
homology found to the tail domain of myo1c in the databases.  In addition, there was 
evidence that the myo1c tail domain may be extended and flexible due to its lack of 
density in electron micrographs of helical reconstructions of myo1a saturated actin 
filaments (Figure 48) (Jontes and Milligan 1997).  Therefore, we followed the advice of 
Dr. Mark Lemmon (University of Pennsylvania) and turned to algorithms that predict 
secondary structure and match those to protein domains of known structures.  From 
these, we were able to identify the region in the tail domain that binds to the membrane 
and locate residues directly responsible for PIP2 binding.  
 
3.4.1 Identification of a Putative PH Domain 
Our searches in the NCBI database for PIP2 binding proteins with sequence 
homology to myo1c yielded negative results.  Undeterred, we searched for structural 
homologs of the myo1c tail domain using the Phyre server 
(www.sbg.bio.ic.ac.uk/phyre/) to identify a phosphatidylinositol binding site.  
Secondary structural analysis revealed that the myo1c tail domain had homology to PH 
domains, including specific sequence homology to the β1-loop-β2 phosphatidylinositol 
binding region (Figure 10) of PPB PH domains (Isakoff, Cardozo et al. 1998).  This 
region contained the PH domain signature motif of conserved basic residues (K-Xn-
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(K/R)-X-R) (Isakoff, Cardozo et al. 1998; Cronin, DiNitto et al. 2004), which we 
identified in myo1c (Figure 43A). 
Two of the conserved basic residues in the β1-loop-β2 region of PH domains 
have been shown to be crucial for high affinity poly-phosphatidylinositol binding 
(Cronin, DiNitto et al. 2004).  To determine if these residues also play a role in myo1c-
PIP2 interactions, we mutated the corresponding amino acids in a GFP-tail construct  to 
alanines (GFP-tail-K892A and GFP-tail-R903A) (Figure 11).  We expressed GFP-tail, 
GFP-tail-K892A, and GFP-tail-R903A in HEK-293T cells, and purified these proteins 
using a two-step purification scheme as described in chapter 2.  The impact of these 
mutations on myo1c binding to PIP2 will be discussed below. 
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Figure 43 PH domain signature motif 
  Figure 43A-C: Figures were originally published in part in (Hokanson, Laakso et 
al. 2006).  Alignment of mouse myo1c (residues 884 - 908) with the (A) β1-loop-
β2 motif of PH domains, B) vertebrate myosin-I isoforms, and C) eukaryotic 
myosin-Is.  Red bands and residues indicate conserved known basic residues 
important for membrane binding in PH domains, orange residues indicate all other 
basic residues, brown residues indicate conserved hydrophobic patch following 
the second key residue of β2, purple residues indicates conserved threonine at end 
of β2. 
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3.4.2 Signature PH Domain Motif Found in Many Eukaryotic Myosin-Is 
There are eight myosin-Is expressed in humans, myo1a through myo1g.  We 
were able to identify the PH domain signature motif (K-Xn-(K/R)-X-R) in all six short-
tail myosin-Is (Figure 43B).  Therefore, we hypothesized that these short-tail isoforms 
bind to phosphatidylinositols in a manner similar to myo1c.  The two myosin-Is that did 
not contain the PH domain signature motif were myo1e and myo1f, the two long-tail 
isoforms of myosin-I.  Long-tail myosin-Is have the addition of an SH3 and GP-rich 
domain in a C-terminal extension of their tail domains that starts after the first β-strand 
of the identified PH domain signature motif.  This extension contains several positive 
charges that may be positioned for phosphatidylinositol binding.  Long-tail myosin-I 
isoforms have been shown to bind acidic phospholipids (Adams and Pollard 1989; 
Stoffler, Ruppert et al. 1995), so it is possible that differences in this region may result 
in differences in membrane binding properties. 
We also identified the PH domain signature motif in myosin-Is from other 
Eukaryotic species, including 61F and 31DF from Drosophila, hum-5 and hum-1 from 
C. elegans, and Myo3 and Myo5 from S. cerevisiae (Figure 43C).   These myosin-Is 
may also bind to phosphatidylinositols in a manner similar to myo1c. 
  
3.4.3 Point Mutations Inhibit PIP2 Binding 
We used sedimentation assays to calculate the effective dissociation constants, 
which are expressed in terms of total lipid (Keff
lipid
) or accessible acidic phospholipid 
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(Keff
acidic
), for the interaction between GFP-tail, GFP-tail-K892A, and GFP-tail-R903A 
and sucrose-loaded 2% PIP2 LUVs (Figure 44).   GFP-tail, GFP-tail-K892A, and GFP-
tail-R903A were sedimented in the presence of 0 – 400 µM LUVs.  The supernatants 
were analyzed for the presence of GFP using a fluorimeter with a double 
monochromator to decrease the amount of light-scattering caused by the LUVs.  
Because the constructs were GFP fusion proteins, we were able to determine the 
fraction bound as a function of lipid concentration by monitoring the loss of 
fluorescence in the supernatant.  The GFP-tail bound with Keff
lipid
 = 24 ± 2.4 μM 
(Keff
acidic
 = 0.24 ± 0.024 μM), which is almost identical to the Keff
lipid
 for a myo1c-tail
 
construct expressed in sf9 cells that does not contain GFP (Table 1).  Remarkably, we 
did not detect any binding of GFP-tail-K892A and GFP-tail-R903A mutants to LUVs 
containing 2% PIP2 at total lipid concentrations of up to 400 µM. 
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Figure 44 Association of GFP-tail constructs with PIP2 
Figure 44: Figure was originally published in (Hokanson, Laakso et al. 
2006).  Lipid concentration dependence of () 6.9 nM GFP-tail, () 
9.7 nM GFP-tail-K892A, and () 15 nM GFP-tail-R903A binding to 
LUVs composed of 2% PIP2.  Each point is the average of two 
measurements.  The solid line is the best fit of the GFP-myo1c-tail data 
to a hyperbola, yielding, Keff
lipid
 = 53 ± 11 μM.   
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3.4.4 Full-Length Myo1c Localization is Identical to Myo1c-Tail 
In all cell types tested (NRK, COS-7, CHO, HeLa, and 293T), GFP-tail was 
localized to the cell membrane and was concentrated in regions of membrane ruffling 
and retraction (Figure 39), as reported previously for endogenously expressed myo1c in 
NRK cells (Ruppert, Godel et al. 1995) and GFP-myo1c in NIH3T3 cells (Bose, 
Guilherme et al. 2002).  In NRK cells, full length GFP-myo1c constructs that contained 
the K892A (GFP-myo1c-K892A) and R903A (GFP-myo1c-R903A) mutations were 
localized to the cytoplasm, with no significant population in the dynamic cell margins 
(Figure 45).  Therefore, no significant population of GFP-myo1c-K892A and GFP-
myo1c-R903A bound to the plasma membrane.  We also tested a GFP-tail construct 
with a K296A mutation.  This construct showed identical localization to GFP-tail, 
suggesting that not all basic residues in this region are essential for membrane 
association, and that membrane binding is not based on charge alone. 
  To test for dominant negative effects on motility and cell morphology, 
particularly at the cell edge, we over expressed GFP-myo1c-tail, GFP-myo1c-tail-
K903A, and GFP-myo1c-K903A in NRK, COS-7, and CHO cells.  We were unable to 
detect any differences in transfected versus nontransfected cells regarding cell size, 
ruffling, lamellipodia, filopodia, endocytosis, mitosis, and cell motility. 
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Figure 45 GFP-my1oc constructs localization 
 
  
Figure 45: Figure was originally published in (Hokanson, Laakso et al. 
2006).  Epifluorescence micrographs of live NRK cells expressing (top) 
GFP-myo1c, (center) GFP-myo1c-K892A, and (bottom) GFP-myo1c-
R903A.  The boxes outline the expanded regions shown in the right column.  
Note the localization of wild-type GFP-myo1c within the membrane ruffles 
and macropinocytic regions, but not in the mutated proteins.  The scale bars 
are 15 µm. 
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3.5 TIRF/FRAP Dissociation Studies 
 TIRF is a technique designed to reduce the background fluorescence of a 
specimen due to the nature of the evanescent electromagnetic field, which decays 
exponentially from the interface and thus penetrates to a depth of approximately 100 nm 
into the sample medium. We combined TIRF with FRAP to measure dissociation rates 
of membrane-bound myo1c.  This technique allowed us to monitor events that occurred 
at and directly above the plasma membrane without the background fluorescence of the 
entire cytosol. 
 
3.5.1 Point Mutations in the Putative PH Domain Affect Myo1c Localization 
We monitored membrane association of GFP-tail, GFP-tail-K892A, and GFP-
tail-R903A by TIRF/FRAP microscopy in live NRK cells to determine if the K892A 
and R903A mutations affect the dynamics of in vivo membrane binding (Figure 46).  
The fluorescence of all constructs was visible by TIRF microscopy, as was the 
fluorescence from cells expressing GFP only.   The fluorescence after photobleaching 
of GFP-tail recovered in two phases.   A fast phase (kfast) recovered within the first 
acquisition point (> 1 s-1), and a slow phase (kslow) recovered with an average rate of 
0.060 ± 0.037 s-1 (Table 4).   kslow ranged between 0.013 – 0.15 s-1 in the eighteen 
cells examined by TIRF/FRAP, but in all cases kslow was clearly resolved from kfast.   
Because myo1c binds acidic lipids at a diffusion-limited rate (Tang, Lin et al. 2002), we 
interpreted the slow recovery time to be the rate at which the photobleached GFP-
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myo1c-tail dissociated from the membrane and the fast recovery to have been the 
diffusion of GFP-tail in the cytoplasm.   
The fluorescence after photobleaching of GFP-tail-K892A and GFP-tail-R903A 
almost completely recovered within the first acquisition point at a rate > 1 s
-1
, a 
response similar to control cells expressing GFP alone.  Also, no slow phase was 
detected, which suggested that the myo1c proteins containing point mutations did not 
bind to the membrane.  These results were consistent with the in vitro binding data 
(Figure 44). 
To make certain the motor domain would not compensate for the point 
mutations in the tail domain of myo1c, we repeated these experiments with full length, 
GFP-tagged constructs.  Again, the fluorescence of GFP-myo1c after photobleaching in 
TIRF/FRAP experiments recovered in two phases.  The kinetics of the recovery phases 
were nearly identical to GFP-tail, indicating that the actin binding domain did not 
contribute significantly to the lifetime of plasma membrane attachment of the over-
expressed protein (Table 4).   The fluorescence after photobleaching of GFP-myo1c-
K892A and GFP-myo1c-K903A almost completely recovered within the first 
acquisition point at a rate of > 1 s-1, confirming that the mutations in the full length 
protein did not bind tightly to the membrane.   Therefore, we concluded that myo1c 
bound to membranes in vitro and in vivo via a region in the tail domain that was in part 
structurally homologous to the phosphatidylinositol binding site in certain PH domains. 
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Figure 46 TIRF/FRAP of myo1c-tail constructs 
 
  Figure 46: Figure was originally published in (Hokanson, Laakso et al. 2006).   
TIRF/FRAP experiments of single NRK cells expressing (top row) GFP-tail, 
(center row) GFP-tail-K892A, and (bottom row) GFP-tail-R903A.  (Left 
column) TIRF micrographs of NRK cells before photobleaching.  The boxes 
outline the photobleached regions.  The scale bar is 15 µm.  (Center columns) 
Normalized time-lapse images of the photobleached regions (see chapter 2); 
elapsed times are given relative to the start of the bleach pulse.  (Right column) 
Fluorescence recovery of GFP after photobleach.  The bleach pulse occurs at 
time-zero.  The solid line in the top graph is a fit of the data from this cell to the 
sum of two exponential rates (kslow = 0.10 ± 0.010 s
-1
).   
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3.5.2 Myo1c Tail Domain is Sufficient for Membrane Localization 
To test whether the IQ motifs in the regulatory domain are necessary for 
membrane binding in live NRK cells, we performed TIRF/FRAP microscopy of GFP-
myo1c-tail
IQ2-3
, GFP-myo1c-tail
IQ3
, and GFP-myo1c-tail
IQ0
 (Figure 11).  The 
fluorescence after photobleaching of these constructs recovered in two phases, as seen 
with GFP-tail (Table 4).  The fast phases recovered within the time resolution of the 
experiment (> 1 s-1), and the slow phases recovered with average rates between 0.041 – 
0.049 s
-1
, which were not significantly different from the kslow determined for GFP-tail.  
Therefore, the regulatory domain was not necessary for membrane association in vivo.  
However, this finding did not rule out a role for the regulatory domain in targeting the 
motor to specific subcellular regions. 
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Table 4 Rates of fluorescence recovery from TIRF/FRAP experiments. 
 
Myo1c constructa kslow (s
-1)b Rangec 
GFP-tail (18) 0.060 ± 0.037 0.013 – 0.15 
GFP-myo1c (10) 0.050 ± 0.028
 0.017 – 0.096 
GFP-tail-K892A (4) > 1 s
-1 > 1 s-1 
GFP-tail-R903A (7) > 1 s-1 > 1 s-1 
GFP-myo1c-K892A (7) > 1 s-1 > 1 s-1 
GFP-myo1c-R903A (9) > 1 s-1 > 1 s-1 
GFP only (4) > 1 s-1 > 1 s-1 
GFP-myo1c-tailIQ2-3 (11) 0.049 ± 0.028 0.018 – 0.087 
GFP-myo1c-tailIQ3 (16) 0.050 ± 0.021 0.019 – 0.089 
GFP-myo1c-tailIQ0 (15) 0.041 ± 0.012 0.012 – 0.094 
aThe number of FRAP transients is reported in the parentheses. 
bValues of kslow were determined from fitting the data to the sum of two 
exponential transients.  Values of kfast determined from the fits are as fast as 
the time resolution of the acquisitions and are not reported.   Errors are 
standard deviations. 
  cThe minimum and maximum values for the experimental set of  kslow values. 
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4 Discussion 
 This chapter will interpret the results from chapter 3 and foresee their 
implications on the association of myo1c with the plasma membrane.  Included will be 
the relevance of PIP2 binding and the resulting specific interaction of myo1c with the 
membrane.  The binding domain will be modeled and the mechanism of binding will be 
related to other membrane binding, as well as the force and dynamics of motors while 
bound to the membrane. 
 
4.1 Mechanism of Membrane Binding 
4.1.1 Original Hypothesis 
  It has been known since 1989 that myosin-Is are localized to the plasma 
membrane and bind to vesicles of anionic lipids (Adams and Pollard 1989).  Myo1c has 
been shown to bind to LUVs composed of increasing molar concentrations of PS with 
increasing affinity (Tang, Lin et al. 2002).  The regulatory and tail domain of myo1c has 
clusters of positively charged arginines and lysines, with an estimated pI of 10.8.  
Before this study, it was believed that the association of myo1c with the plasma 
membrane was primarily based on non-specific electrostatic interactions (Hayden, 
Wolenski et al. 1990; Doberstein and Pollard 1992).  We initially modeled one patch of 
basic residues, PEWKQQLQQKAVASEIFKGKK, as an α-helix using Swiss PDB 
Viewer (Figure 47A-B); it appeared as an amphiphatic helix with all of the basic 
charges aligned on one side of the helix.  Therefore, we originally predicted this cluster 
of positive charges to be the lipid binding site of myo1c. 
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Figure 47 Predicted lipid binding site 
  Figure 47A-B: A predicted α-helix calculated with Swiss PDB viewer and 
stylized using Pymol.  The structure was predicted using energy minimizations of 
the sequence from the text.  A) Predicted α-helix, basic residues are displayed in 
blue, aromatic residues are displayed in gold.  B)  Electrostatic potential map of 
the helix in “A”.  Note the amphiphatic nature of the helix with basic residues 
facing the top side.  
A 
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4.1.1.1 Electrostatic Binding  
Like myo1c, MARCKS has been shown to bind PS through electrostatic 
interactions (McLaughlin, Wang et al. 2002).  The ED of MARCKS has been well 
studied and contains 13 basic residues, five phenylalanines, and a myristoylated N-
terminus (Figure 8).  MARCKS has no set structure when it is bound or unbound to the 
membrane (Arbuzova, Schmitz et al. 2002).  It combines myristoylation, hydrophobic 
insertions, and electrostatic interactions to bind to the plasma membrane in a non-
specific manner.  Based on binding data from MARCKS (McLaughlin, Wang et al. 
2002) and helical reconstructions of a myosin-I showing the lack of electron density in 
the tail domain (Figure 48) (Jontes and Milligan 1997), we initially hypothesized that 
myo1c bound to the membrane in a non-specific manner similar to the ED of 
MARCKS.  We further hypothesized that the structure of the myo1c tail domain might 
be disordered and that interacting with the membrane could induce the folding of an 
amphiphatic helix, creating a highly concentrated positive electrostatic potential that 
would bind to the negatively charged membrane.  Membrane localization of the ED of 
MARCKS requires an interaction with multiple PS molecules. It was predicted and 
subsequently demonstrated that the ED preferentially bound to lipid headgroups in 
which the negative charges were already clustered.  The prime candidate for a lipid with 
such a head group was PIP2, which has a charge of -4 at pH 7 (McLaughlin, Wang et al. 
2002).  Since PIP2 only contributes ~ 1% of the plasma membrane, the binding 
interaction between myo1c and PIP2 would have to require a tight 1:1 stoichiometry of 
myo1c : PIP2, or a cooperative binding to multiple PIP2 molecules. 
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Figure 48 3D model of myo1a 
 
  
Figure 48A-C: A three dimensional model of myo1a from (Jontes 
and Milligan 1997).  A) M, motor domain; LC1, 2, and 3, the three 
CaM light chains; LB, lipid binding domain. The deduced actin 
binding site is indicated by the arrow. The plane of the membrane 
is illustrated by the dotted lines. B) and C) are side views of the 
model.  The scale bar represents 45 Å. 
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4.1.1.2 Myo1c Binds PIP2 Headgroup  
To determine if MARCKS’s non-specific binding mechanism was an 
appropriate model for the interaction between myo1c and PIP2, we measured the 
binding of myo1c-tail to PIP2 and found that like MARCKS, myo1c bound PIP2 
preferably over PS (Table 1).  However, unlike proteins with polybasic EDs, 
(McLaughlin, Wang et al. 2002) , the interaction did not appear to be cooperative, as 
determined by the lack of a lag phase when myo1c bound to increasing molar 
concentrations of PIP2 (Figure 29).  In addition, myo1c was unable to cluster multiple 
PIP2 molecules together upon binding to the membrane, as measured by FRET.  
Moreover, we determined that myo1c bound to Ins(1,4,5)P3 directly, and that this 
interaction was slightly tighter than that for PIP2.  Proteins with polybasic EDs cannot 
bind to soluble inositol phosphates derivatives because they are not presented in a 
multivalent manner within the membrane like phosphatidyl inositols.  This is referred to 
as a reduction of dimensionality and can increase the effective concentration of a 
substrate 1000-fold (Adam 1968).  Thus, the interaction of myo1c for PIP2 was not 
cooperative, but specific for the headgroup of the lipid.  This led us to form a new 
hypothesis that the mechanism of myo1c binding to the membrane was more similar to 
the specific interaction of PLCδ-PH with PIP2 (Lemmon and Ferguson 2001) rather 
than the electrostatic interaction of the polybasic ED of MARCKS with multiple PIP2 
molecules. 
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4.1.2 Myo1c Tail Domain Binds PIP2 
We now know that myo1c binds to the membrane through a specific interaction 
with the head group of PIP2 and other phosphatidyl inositols.  The myo1c tail domain is 
necessary and sufficient to localize myo1c to the membrane.  This high affinity 
interaction drives the association of myo1c to the plasma membrane and other 
membrane regions rich in poly-phosphatidyl inositols.  We show through sedimentation 
assays that myo1c binds PIP2 with a partition coefficient of Keff
acidic
 = 0.23 µM.  The 
interaction of myo1c with PIP2 has a 1:1 stoichiometry as evidenced by our data from 
PIP2 molar percentage experiments, as well as our data showing that myo1c can bind to 
Ins(1,4,5)P3.  All evidence points to a similar binding mechanism to the canonical PIP2 
binding PLCδ-PH domain.  This similarity is further supported by our data showing that 
mutating one of two conserved residues of the PH domain signature motif, both 
essential for PIP2 binding in certain PH domains, in the myo1c-tail completely 
eradicates binding to PIP2 and membrane localization. 
Many PH domains contain a specific binding pocket for the phosphorylated 
inositol rings of phosphatidyl inositols.  These pockets are made up of multiple 
hypervariable loops that form hydrogen bonds to the phosphates on the inositol rings of 
phosphatidyl inositols (Lemmon and Ferguson 2001).  The first of these loops between 
β-strand 1 and β-strand 2 is where the PH domain signature motif lies.  Slight variations 
in the non-conserved residues found on these loops give rise to the binding specificity to 
particular phosphatidyl inositols (Cronin, DiNitto et al. 2004).    We found that myo1c 
bound promiscuously to many inositol phosphates through our competitive inhibition 
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assays.  Although no structure is known for the tail domain of myo1c, we hypothesize 
that it contains a binding pocket made up of loops containing basic residues required for 
hydrogen bonding with the phosphates of phosphatidylinositols.  Myo1c shares 
sequence homology with many other myosin-I isoforms from vertebrates and other 
eukaryotes; slight differences in the non-conserved residues of these loops may lead to 
stereo-specific interactions with particular phosphatidyl inositols, much like that seen in 
the hypervariable loops of PH domains (Lemmon and Ferguson 2001).  This would lead 
to an isoform specific localization of myosin-Is in the cell due to the non-uniform 
expression and localization of phosphatidyl inositols.  Although all of our membrane 
binding data with myo1c supports characteristics of its tail domain containing a 
phosphatidylinositol binding PH domain, we are unable to classify it as a PH domain 
because no structure is known.   
 
4.1.3 Biological Relevance of PIP2 Binding 
Phosphatidylinositols are concentrated in actin-rich structures where they 
regulate the activity of several cytoskeletal proteins, including activators of the Arp2/3 
complex, actin severing and capping proteins, and actin monomer binding proteins 
(Insall and Weiner 2001; Yin and Janmey 2003).  PIP2 production spatially and 
temporally regulates phagocytosis, macropinocytosis, endocytosis, ion channel function 
and cell protrusion. Myosin-I isoforms are also enriched in these regions and function in 
these processes (Yin and Janmey 2003).  One role of phosphatidylinositols in actin-rich 
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structures may simply be to serve as spatially and temporally regulated membrane 
anchors for myosin-I isoforms, allowing the recruitment of myosin-I to function in 
endocytosis (Novak, Peterson et al. 1995; Jung, Wu et al. 1996; Swanson, Johnson et al. 
1999; Ostap, Maupin et al. 2003), secretion (Bose, Guilherme et al. 2002), and 
membrane retraction.  However, myosin-I isoforms may also use their barbed-end-
directed motor activity to keep the fast-growing ends of the actin filament oriented 
toward the membrane and phosphatidylinositol regulators of the cytoskeleton (Jung, 
Remmert et al. 2001).   
Myosin-I isoforms may also link phosphatidylinositols to other regulatory 
proteins.  For example, -catenin and dynamin have been shown to bind myosin-I in 
Drosophila, where they play a role in the control of left-right asymmetry during 
development (Hozumi, Maeda et al. 2006; Speder, Adam et al. 2006).  However, the 
function of myosin-I in these processes is not understood, and it is not known if the 
motor and phosphatidylinositol binding activity of myosin-I drives the localization of 
these proteins, or if myosin-I is targeted to specific regions by binding to these proteins.  
PHR1, a recently identified integral membrane protein present in the sensory cells of the 
inner ear, binds myo1c and may link it to stereocilia membranes (Etournay, El-Amraoui 
et al. 2005).  Myo1c is the likely motor that drives mechanical adaptation in hair cells 
(Batters, Arthur et al. 2004; Gillespie and Cyr 2004), and depletion of PIP2 inhibits this 
adaptation (Hirono, Denis et al. 2004).  Therefore, it is likely that PHR1 and PIP2 act to 
link myo1c to the adaptation complex (Hirono, Denis et al. 2004; Etournay, El-Amraoui 
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et al. 2005).  It is interesting to speculate that control of the levels of membrane 
phosphatidylinositol regulates the assembly of this motor complex. 
   
4.1.4 The Regulatory Domain and Membrane Association 
  The original hypothesis of a membrane induced, α–helical binding site could 
still hold true for a separate, secondary membrane binding site.  In fact, our data showed 
that there was an electrostatic component to the binding of myo1c to the membrane, 
given that myo1c bound to LUVs comprised of ≥ 60% PS and that the addition of NaCl 
was able to inhibit binding of myo1c to either LUVs of PS or PIP2.  However, it is more 
likely that our data supports a model which implicates the regulatory domain as the 
secondary binding site of myo1c (Swanljung-Collins and Collins 1992; Tang, Lin et al. 
2002; Hirono, Denis et al. 2004).  This model was derived from the existence of several 
basic residues in the three IQ motifs of the regulatory domain.  A Ca
2+
-induced 
conformational change or dissociation of one or more of the three CaM bound to the IQ 
motifs could reveal positive charges (Figure 31).   
  Our sedimentation assays confirmed that the regulatory domain of myo1c was 
capable of binding negatively charged phospholipid membranes in vitro in a Ca
2+
-
dependent manner, as proposed for myo1a (Collins and Swanljung-Collins 1992) and 
myo1c (Tang, Lin et al. 2002; Hirono, Denis et al. 2004).  A myo1c construct lacking 
the tail domain but still containing the regulatory domain was able to bind to LUVs 
comprised of ≥ 40% PS with high affinity in the presence of 10 µM Ca2+.  We also 
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found that the affinity of the myo1c-tail interaction increased ~5-fold with the inclusion 
of 20% PS in LUVs that contained 2% PIP2.  This indicated that the regulatory domain 
could potentially play a secondary role in membrane attachment, with the primary 
association occurring via phosphatidylinositol-tail interactions.  Nevertheless, this 
secondary binding site alone could not explain the physiological binding of myo1c to 
the membrane since the typical inner leaflet of the membrane contains less than 30% 
PS.  For myo1c to bind to the plasma membrane in a cell, it must rely on its primary 
lipid binding site in the tail domain.     
TIRF/FRAP experiments revealed that the regulatory domain was not necessary 
for plasma membrane association in live cells.  Although the high expression levels of 
the GFP constructs and the short acquisition integration time prevented us from 
confidently examining subtle changes in subcellular localizations, we were able to 
detect membrane binding of GFP-myo1c-tail
IQ0
 with dissociation rates similar to GFP-
myo1c.  One can speculate that although the motor and regulatory domains are not 
required for membrane association, they may have an effect on the subcellular 
localization to micro domains on the membrane.  In fact, the motor domain has been 
shown to be required for correct subcellular localization of other myosin-Is (Ruppert, 
Godel et al. 1995; Tang and Ostap 2001; Bahler and Rhoads 2002); however, our IQ 
motif deletion constructs did not contain a motor domain, so we could not study this 
directly.  Although we could rule out the requirement of the regulatory domain for 
142 
 
 
plasma membrane attachment, further experiments are required to determine its role in 
myosin-I targeting (Cyr, Dumont et al. 2002). 
 
4.2 Discovery of the PIP2 Binding Site.   
4.2.1 Identifying a Putative PH Domain 
We were able to identify the PIP2 binding site of myo1c through discovering 
predicted secondary structure homology to a specific region in poly-
phosphatidylinositol binding (PPB) PH domains.  This region contained the PH domain 
signature motif of conserved basic residues (K-Xn-(K/R)-X-R) (Isakoff, Cardozo et al. 
1998; Cronin, DiNitto et al. 2004).  We validated this sequence similarity to PPB PH 
domains by testing single point mutations in our myo1c construct that are conserved 
and known to disrupt PIP2 binding in these domains.  As with PPB PH domains that 
contain (K-Xn-(K/R)-X-R), these point mutations completely eradicated myo1c binding 
to PIP2 in vitro and disrupted membrane localization in vivo.  These data supported our 
finding that the tail domain of myo1c is both sufficient and necessary for membrane 
localization in the cell. 
In a collaboration with Dave Sept (Washington University, St. Louis, MO), we 
preformed ab initio structural prediction calculations of residues P802-R1028 within the 
myo1c tail domain.  These calculations resulted in a modeled structure that could not be 
classified as a PH domain, but showed some structural similarity to PH domains (see 
chapter 2).  These similarities included the β1-loop-β2 region (Figure 49B) and a -
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sheet core structure, although it was not continuous (Figure 49A).  Specifically, when 
compared with the PH domain of PDK1, we saw that the structural alignment over the 
β1-loop-β2 region was very good (Figure 49), giving a protein backbone RMSD of 3.5 
Å with a sequence identity of 61% (Figure 43).  However, the computation predicted 
neither a seven stranded β-sheet core, nor a distinct C-terminal α-helical cap as defined 
in all PH domain structures (Lemmon and Ferguson 2001), which may have been a 
limitation of the computational method, or may reflect actual differences in the 
structure. 
 
Figure 49 Predicted PIP2 binding structure 
Figure 49A-B: Figure was originally published in (Hokanson, Laakso et al. 2006).  
A) Predicted structure for the myo1c tail region (orange) compared with the Pdk1 
structure (green).  (B) Detailed comparison of the β1-loop-β2 region of PDK1 and 
the predicted structure of the Myo1c tail.  Two of the residues in Pdk1 involved in 
coordinating the Ins(1,3,4,5)P4 molecule align with our two mutations at K892 and 
R903 (see sequence inset). 
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Since our ab initio modeling cannot identify a PH domain in the myo1c tail, it is 
possible that this region is a novel PIP2 binding motif with only partial sequence and 
structural elements similar to PH domains.  It is also possible, and perhaps likely, that 
the ab initio model is wrong.  Low electron density of the tail domain from electron 
microscopy and helical reconstructions suggests this region may be flexible (Jontes and 
Milligan 1997).  A flexible region could enable a myo1c bound to PIP2 to bind to an 
actin filament at various places along its helical pitch.  Therefore, more binding sites 
would be available on a given actin filament, which would increase the chance of it 
binding to myo1c as it approaches the membrane from varying angles. 
This alternative model is quite intriguing since it may lead to the discovery of a 
new phosphatidyl inositol binding domain found among the short-tail vertebrate 
myosin-Is, as well as myosin-Is from many other eukaryotes.  As discussed earlier, 
slight differences in sequence could lead to subtle changes in spatial or temporal 
localization.  Defining this binding site is an important step in our understanding of the 
interaction between myosin-Is and the membrane.  Knowing which residues are 
important to membrane binding will help in the understanding of diseases and drug 
targeting involving myosin-I motors. 
Further characterizing this domain will also help in understanding the seemingly 
redundant nature of expressing multiple myosin-I isoforms in the same cell.  It has been 
shown that knocking down the expression of a single myosin-I isoform shows little to 
no phenotype in some cells because there are complimentary myosin-I isoforms that 
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will take its place (Jung, Wu et al. 1996).  In fact, a myo1a knock out mouse showed 
ectopic recruitment of myo1c to the region where myo1a normally resides (Tyska, 
Mackey et al. 2005).  In many of the cases studied, there appears to be an overlap of 
localization as well as function.  Myo1c and myo1e are both found at the vesicles 
containing cortical granules within a short time span, yet play unique roles (Sokac, 
Schietroma et al. 2006; Schietroma, Yu et al. 2007).  We found no obvious dominant 
negative effects from the over-expression of either GFP-tail or GFP-myo1c-R902A 
(Figure 40). To further define the membrane binding domain, detailed structural 
information is imperative.  This will allow a better understanding of the structural 
diversity within the myosin-I isoforms needed to decipher their overlapping, but 
possibly non-redundant functions.   
 
4.2.2 Inositol Phosphate Specificity 
We showed through gel filtration and competitive binding assays that myo1c 
bound to inositol phosphates directly with similar affinities to PIP2.  These affinities 
were similar to those of PH domains specific for inositol phosphate Ins(1,4,5)P3, 
including PLCδ, Kd = 0.21 µM (Lemmon, Ferguson et al. 1995), Ins(1,3,4,5)P4, 
including Btk, Kd = 0.040 µM (Baraldi, Carugo et al. 1999), and Pdk1, Kd = 0.014 µM 
(Komander, Fairservice et al. 2004).  We found that although myo1c seemed to be quite 
promiscuous and bound to most of the inositol phosphates with affinities within a factor 
of three, it bound to Ins(1,2,6)P3 with a 10-fold weaker affinity and did not bind 
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Ins(3)P1 detectably.  Therefore, the binding affinity was not based on the charge of the 
inositol phosphate alone, but was dependent on the positions of the phosphates on the 
inositol ring.  Our experiments suggested that phosphates at the 4 or 5 positions were 
required for tight binding, while phosphates at the other positions did not prevent 
binding. 
Myo1c should be able to bind lipids that have headgroups listed in Table 3, with 
PIP2 (Ins(1,4,5)P3 headgroup) and PIP3 (Ins(1,3,4,5)P4 headgroup) being the most 
prevalent in the membrane and the most relevant to the proposed functions of myo1c 
(Yin and Janmey 2003).  The plasma membrane concentration of PIP2 is much higher 
than PIP3 in both unstimulated and stimulated cells (Insall and Weiner 2001; Dormann, 
Weijer et al. 2002).  Thus, in the absence of other phosphatidylinositol binding proteins, 
we would expect myo1c to interact with PIP2 based on its higher concentration 
(McLaughlin and Murray 2005).  However, our in vitro biochemical experiments may 
not take into account the presence of other cellular phosphatidylinositol binding 
proteins.  Further cellular experiments are required to determine in vivo specificity and 
binding of myo1c. 
 
4.2.3 Phosphatidylinositol Binding by Other Myosin-I Isoforms 
Alignment of myo1c with the seven other vertebrate myosin-I isoforms showed 
sequence conservation in the β1-loop-β2 motif region of the putative PH domain.  The 
highest sequence similarity was among the short tail myosin-I isoforms (myo1a, myo1b, 
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myo1c, myo1d, myo1g).  Thus, we proposed that the short-tail isoforms will bind to 
phosphatidylinositols in a manner similar to myo1c.  We also found extended sequence 
similarities of this region to myosin-Is from other species including 61F and 31DF from 
Drosophila, hum-5 and hum-1 from C. elegans, and Myo3 and Myo5 from S. 
cerevisiae.  However, given that this region was not completely conserved, it is possible 
that the different short-tail isoforms differ in their phosphatidylinositol affinity and 
specificity.  This would enable different myosin-I isoforms to localize to different sub-
regions on the plasma membrane depending on local concentrations of 
phosphatidylinositols. 
Long-tail myosin-I isoforms have been shown to bind acidic phospholipids 
(Adams and Pollard 1989; Miyata, Bowers et al. 1989; Stoffler, Ruppert et al. 1995).  
However, vertebrate long-tail myosin-I isoforms (myo1e and myo1f) contain only the 
N-terminal portion of the PH domain signature motif.  Although their sequences diverge 
from the signature motif in the putative loop region, they do contain several positive 
charges that may be positioned for phosphatidylinositol binding.  It is possible that 
without hypervariable loops like those found in PPB PH domains, myo1e and myo1f 
may bind to the membrane in a manner more similar to the ED of MARCKS than to a 
PH domain. 
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4.3 Myo1c Lipid Binding Sites 
4.3.1 Physiological Role of Binding PIP2 
We hypothesize that since levels of PIP2 in the inner leaflet of the plasma membrane 
are estimated to be 5 - 10 µM, which is 10 – 1000 fold higher than most other 
phosphatidyl inositols (PtdIns4P is 3 µM) (Stephens, Jackson et al. 1993; McLaughlin, 
Wang et al. 2002), myo1c will more often bind PIP2 preferentially over other 
phosphatidyl inositols.  This leads to important implications within the cell including 
subcellular localization, PIP2 sequestering, limited lateral diffusion rates, possible 
regulation, and tight binding. 
 
4.3.1.1 Localization to High Concentrations of PIP2 at the Membrane 
PIP2 has been implicated to exist at high local concentrations on the plasma 
membrane and in membrane structures within the cell (McLaughlin, Wang et al. 2002).  
This can be due to synthesis of PIP2 at these regions, sequestering and clustering of PIP2 
by proteins, or segregation of PIP2 into micro-domains.  A higher local concentration 
should result in the recruitment of myo1c.  This not only affects the spatial localization 
of myo1c, but also the temporal localization; additionally, the local concentrations of 
PIP2 in the cell can be very dynamic.  We have shown an example of this in NRK cells 
where myo1c tracks with a macropinosome enriched with PIP2.  One of the most 
important implications of high local concentrations of PIP2 for myo1c is the role of 
myo1c as a motor in the adaptation response in hair cells.   
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4.3.1.2 Role of PIP2 Binding in Hair Cells 
PIP2 has a distinct distribution in hair cells, being present only above the ankle link 
region of stereocilia and excluded from the basal region and apical surface of hair cells 
(Hirono, Denis et al. 2004).  Inhibition of PIK4 reduces the rates of both slow and fast 
adaptation and causes a loss in transduction current (Hirono, Denis et al. 2004).  Myo1c 
is required for the slow and fast adaptation in hair cells (Holt, Gillespie et al. 2002; 
Gillespie 2004), and it has been shown that the second IQ motif is necessary for proper 
myo1c localization in stereocilia (Cyr, Dumont et al. 2002; Phillips, Tong et al. 2006).  
The second IQ motif of myo1c is thought to interact with the cytoplasmic domain of 
cadherin 23, a component of the tip link, but is not sufficient for proper localization 
(Siemens, Lillo et al. 2004; Phillips, Tong et al. 2006).  From these and other studies it 
is clear that the mechano-signal transduction and the adaptation response in hair cells 
requires both PIP2 and myo1c.  
We hypothesize that disrupting PIP2 levels in hair cells disrupts the ability of myo1c 
motors to be linked to the transduction channel and facilitate an adaptive response.  One 
model that would explain this is that myo1c binds to PIP2 through its tail domain and 
cadherin 23 through its second IQ motif, linking myo1c to both the transduction 
apparatus and to the surrounding membrane while it is bound to the bundled actin 
filaments through its motor domain.  These interactions could cluster the estimated 
ensemble of 50 – 200 myo1c motors to the transduction apparatus and enable them to 
adapt to the transduction channel opening.  Without either of these interactions present, 
transduction ceases and adaptation is lost. 
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An opposing model is that the IQ motifs bind to both cadherin 23 and PIP2.  Since 
the IQ motifs of myo1c are highly basic, it is reasonable to assume that they could 
provide a secondary binding sight to a high local concentration of PIP2 and would be 
sufficient for localization.  In fact, this has been confirmed using PIP strips (Hirono, 
Denis et al. 2004) and a myo1c construct containing only the IQ motifs.  However, we 
believe that this interaction is not physiological and only exists due to the abnormally 
high density of PIP2 present on the PIP strips, as our myo1c-motor construct did not 
bind to up to 10% PIP2 LUVs.  Any positively charged peptide is likely to bind to PIP 
strips; however, this does not mean that it will bind to PIP2 at physiological 
concentrations in the cell.  Therefore, I believe that the IQ motifs are responsible for 
binding to cadherin 23 or another transduction apparatus receptor, and that the tail 
domain is responsible for binding to PIP2. 
 
4.3.1.3 Sequestering PIP2 
We showed that myo1c is unable to cluster multiple PIP2 molecules together; 
however, one can imagine how multiple myo1c molecules decorating an actin filament 
might be able to align a string of PIP2 molecules along the actin filament.  In a branched 
network of actin filaments close to the plasma membrane, this could create a high 
density of PIP2 molecules that have a low lateral diffusion coefficient and are unable to 
bind to other proteins.  A secondary effect of this is that if PIP2 binds laterally to 
intermembrane proteins, this would give rise to the pickets in the picket fence model 
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that correlates with the mesh size of the actin cytoskeleton.  More on this will be 
discussed later.  Through a signaling event or regulation of myo1c, these PIP2 
molecules could be released, creating a local high concentration of PIP2 for other 
proteins to bind.  This has been shown previously with MARCKS protein which can 
bind to multiple PIP2 molecules (Glaser, Wanaski et al. 1996). 
Our digestion experiments with trypsin revealed that myo1c is protected from 
digestion in the presence of Ins(1,4,5)P3.  Binding to PIP2 in the cell may protect myo1c 
from being degraded by protecting sites targeted by proteinases.  Selecting non-
membrane bound myo1c for degradation could be a way to regulate the over-expression 
of myo1c and limit its presence in the cytoplasm.  
 
4.3.2 Physiological Role of the Regulatory Domain in Membrane Association 
The primary proposed role of the regulatory domains of all myosins is that it 
acts as a lever arm that transduces the force of the motor domain.  It has been shown 
that light chains, most likely CaM, bind to the long single α-helix to give it enough 
rigidity to hold firmly in place during a powerstroke.  Without light chains bound, it is 
thought that the lever becomes flaccid (Zhu, Beckingham et al. 1998).  From our 
binding data collected with the myo1c-motor construct and myo1c-tail with LUVs of 
20% PS and 2% PIP2, it is apparent that the regulatory domain plays a role in membrane 
binding.  Once myo1c has been localized to the plasma membrane via the tail domain 
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binding to PIP2, it is likely that at least one of the IQ motifs will contribute to binding 
by a conformational change or dissociation of a CaM. 
 
4.3.2.1 Sequestering of the Lever Arm 
One consequence of the regulatory domain binding to the membrane is that it 
will shorten the effective lever arm of the motor considerably depending on which of 
the IQ motifs binds to the membrane.  Myo1c has a powerstroke of 4.2 nm (Batters, 
Arthur et al. 2004) and it has been shown that the number of IQ motifs linearly affects 
the length of the working powerstroke of myosin-V (Sakamoto, Wang et al. 2003).  If 
the IQ motif furthest from the motor domain loses its CaM and binds to the plasma 
membrane, it will essentially change the length of the powerstroke from three IQ motifs 
to two.  This shortening of the lever arm could be a way to regulate the length of the 
powerstroke in the cell.  However, if the IQ motif closest to the motor is affected, it will 
also shorten the length of the powerstroke considerably.  This would have a drastic 
affect on the function of the myo1c and may even inhibit it from acting as a 
conventional molecular motor.  In this latter case, myo1c would instead act as a very 
short tether, maintaining a bond between the actin cytoskeleton and the plasma 
membrane. 
Although an IQ motif providing an additional binding site to the plasma 
membrane may shorten the length of the powerstroke, it may provide an additional 
anchoring point.  As will be discussed later in more detail, for a myosin-I to be an 
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effective motor while it is bound to the membrane, it must remain anchored in the 
membrane and not fluid during a powerstroke.  Although it has been shown that PIP2 
has a much lower lateral diffusion rate than other lipids (Cho, Kim et al. 2005), an 
additional binding site to multiple PS molecules may stabilize myo1c positioning on the 
membrane. 
 
4.3.2.2 Stabilizing Myo1c in the Absence of CaM 
Another possibility for the function of the regulatory domain in myo1c binding 
to the plasma membrane is to prevent the aggregation of myo1c.  Ca
2+
 was found to 
prevent myo1c from dissociating from 60% PS LUVs, even after washout with EGTA 
(Tang, Lin et al. 2002).  This suggests that in the presence of excess Ca
2+
, myo1c 
binding to the membrane is irreversible in the absence of excess CaM.  Myosins are 
notorious for aggregating when they are in the absence of light chains.  When a CaM 
dissociates from myo1c, binding to the membrane may be a way for myo1c to prevent 
aggregation, thus stabilizing its regulatory domain and preventing it from binding to 
potentially harmful binding partners that would cause aggregation.  Therefore, the 
plasma membrane could act much like a chaperone protein, binding to unstable regions 
of the protein until a light chain is available for binding.      
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4.3.2.3 Lower Dissociation Rates 
We propose that the main function of the regulatory domain of myo1c bound to 
the membrane is that it changes the kinetics of membrane association by decreasing the 
dissociation rate.  The Keff
lipid
 increases 10-fold when 20% PS is added to LUVs 
comprised of 2% PIP2.  Since association rates are fast and diffusion limited (Tang, Lin 
et al. 2002), the only way to explain this is that the dissociation rates decrease 10-fold.  
This would allow myo1c to proceed through more ATPase cycles (1 s
-1
) while still 
bound to the membrane if it is acting as a motor, or keep myo1c associated with the 
membrane longer if the primary role of myo1c bound to the plasma membrane is to act 
as a tether. 
 
4.4 Force and Function.   
The apparent second-order association rate (ka) of myo1c for 60% LUVs is 
~0.16 µM
-1
 s
-1
.  For binding in terms of LUV concentrations, this rate can be considered 
as diffusion limited at 2 x 10
10
 M
-1
 s
-1
.  (Tang, Lin et al. 2002).  We measured the 
partition coefficient of myo1c to 2% PIP2 + 20% PS LUVs to be Keff
lipid
 = 4.0 ± 1.5 µM.   
If we ignore that Keff
lipid
 is not a true Kd, and that the association rate for 60% PS LUVs 
is the same as for 2% PIP2 + 20% PS LUVs, we can calculate a dissociation rate in 
accordance with: 
Equation 9 
𝐾𝑑 =
𝑘𝑑
𝑘𝑎
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An apparent kd calculated as 0.040 s
-1
 for myo1c dissociating from 2% PIP2 + 20% PS 
LUVs in vitro.  As mentioned, there are limitations to this calculation so this number 
should be taken lightly as an approximation.  This calculated value is in close 
agreement with the in vivo dissociation rates we measured in our TIRF/FRAP 
experiments (0.05 s
-1
).   Since the ATPase rate of myo1c is 1 s
-1
 (Gillespie, Gillespie et 
al. 1999), myo1c should be able to go through ~20 ATPase cycles before dissociating 
from  the membrane at high ATP concentrations.  Whether the ATPase activity of a 
myo1c can produce force relative to the membrane to which it is bound will be 
discussed below. 
It is well established that the plasma membrane is fluid and dynamic.  One of the 
biggest questions that still remains regarding myosin-Is is if they can act as a motor 
while bound to the membrane.  When forces are applied in plane with the membrane, 
can a myosin-I molecule that is bound remain anchored during a powerstroke?  When 
forces are applied perpendicularly, can myo1c stay bound to the membrane, thus 
stretching and deforming the membrane itself, or will it be pulled off?  These are two 
fundamental questions that still need to be answered to understand the functions of 
myo1c. 
 
4.4.1 Forces Planar to the Membrane 
Testing the notion of myo1c remaining anchored in the plasma membrane while 
experiencing forces in plane with the membrane is essential to identifying the possible 
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functions of myosin-Is (Figure 50).  For myo1c to be functional as a motor while bound 
to the membrane, it must be stationary at forces up to 2 pN, the estimated force of a 
myo1c powerstroke (Gillespie and Cyr 2004).  We can estimate the minimum velocity 
of an individual powerstroke of myo1c by dividing the powerstroke distance of 4.2 nm 
by the lifetime of actin attachment 50 ms (Gillespie and Cyr 2004) to get a velocity of 
0.084 µm/s.  To withstand forces of up to 2 pN, the drag coefficient of myo1c on the 
membrane would have to be greater than 2.4 x 10
-11
 N·s/µm in accordance with: 
Equation 10 
𝐹 = 𝑣𝛾 
where F is the force against the plane of the membrane, v is the velocity of the 
powerstroke, and γ is the drag coefficient.  Using the Einstein relation, 
Equation 11 
𝐷 =
𝑘𝑇
𝛾
 
 where D is the lateral diffusion coefficient, and kT is the Boltzman constant at 37 °C, 
4.11 x 10
-15
 N·µm, this would require the lateral diffusion coefficient of a myo1c bound 
to the plasma membrane to be less than 1.7 x 10
-4
 µm
2
/s. 
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Figure 50 Forces planar to the membrane 
 
  
Figure 50: Cartoon of myo1c producing forces planar to the membrane.  
A) Myo1c bound to both actin and PIP2 pre-powerstroke.  B) Myo1c 
bound to the membrane remains stationary as the actin filament is 
translated relative to the membrane after a powerstroke.  C) Actin 
filament remains stationary as myo1c bound to PIP2 laterally diffuses in 
the membrane after a powerstroke. 
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4.4.1.1 Lateral Diffusion 
A diffusion coefficient of 1.7 x 10
-4
 µm
2
/s is much slower than the diffusion 
rates measured for many lipids (6 µm
2
/s) (Scandella, Devaux et al. 1972) and integral 
membrane proteins (0.5-2 µm
2
/s) (Snapp 2003).  Diffusion rates of phosphatidyl 
inositol associated proteins, such as PLCδ-PH domain, have been measured using 
FRAP to be close to cytoplasmic diffusion rates (3.5 µm
2
/s); however, no controls for 
the possibility of the dissociation of bleached proteins from the membrane and 
association of unbleached protein were shown (Brough, Bhatti et al. 2005).  
Additionally, it was found for eGFP-PH123 that the mean-squared deviation in position 
did not increase with time and remained close to the limit of position detection (0.03 
µm
2
) (Mashanov, Tacon et al. 2004).   
Interestingly, the diffusion rate for PIP2 was recently measured to be as low as 
3.9 e
-4
 µm
2
/s in mouse arterial myocytes (Cho, Kim et al. 2005).  The diffusion rate was 
found to be dependent on the cytoskeleton and is ten thousand times slower than other 
phosphatidyl inositols measured in the same study.  PIP2 with a lateral diffusion 
coefficient of 3.9 e
-4
 µm
2
/s would provide the approximate resistance for a myo1c motor 
to translate an actin filament in relation to the plane of the membrane during a 
powerstroke.   
 There are many possibilities that could account for the five orders of magnitude 
difference in lateral diffusion rates between PIP2 and other lipids.  It has been suggested 
that lipids can segregate into microdomains created by mismatches in hydrophobic 
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thickness, van der Waals interactions, and acyl chain entropy (Marguet, Lenne et al. 
2006).  Thus, PIP2 could be segregated into these microdomains which may have a 
lower overall diffusion rate than the rest of the membrane.  Although PIP2 has a 
polyunsaturated chain and should not partition into microdomains without other factors 
acting on it (McLaughlin, Wang et al. 2002), studies have shown that some 
microdomains are enriched in PIP2 (Golub, Wacha et al. 2004).   
A possibility that also accounts for the dependence on the cytoskeleton is that 
the lateral diffusion of PIP2 could be limited by the mesh size of the cytoskeleton, a 
model commonly referred to as the picket fence model (Sako and Kusumi 1995).  In 
this model, it is suggested that the actin cytoskeleton acts as a fence that encloses a 
domain of lipids and lipid-bound proteins.  Transmembrane proteins that are associated 
with the cytoskeleton act as pickets in the membrane and further limit the mobility of 
lipids from diffusing outside of these domains.  The actin cytoskeleton lies close to the 
plasma membrane at just 10.2 nm (Morone, Fujiwara et al. 2006).  The mesh sizes 
created by the actin network differ from cell types, ranging from 0.0027 µm
2
 in FRSK 
cells and to 0.039 µm
2
 in NRK cells.  These measurements correlate well with the 
measured lateral diffusion of a fluorescently labeled phospholipid used in the same 
study, which diffused within a compartment of 0.0021 µm
2
 in FRSK cells and 0.043 
µm
2
 in NRK cells (Morone, Fujiwara et al. 2006).  However, this model alone cannot 
explain the five magnitude difference in lateral diffusion rates of PIP2 to other 
phospholipids.   Incorporating the findings that so many proteins bind to PIP2 and not to 
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other phospholipids might be enough to explain the lower diffusion rates.  The lateral 
diffusion rates of these proteins would be limited by the cytoskeleton, thus limiting PIP2 
bound to them, while phospholipids not bound to proteins would be free to diffuse. 
An alternative explanation is that the low lateral diffusion rates observed for 
PIP2 may be the effect of myo1c binding rather than the cause of myo1c having a low 
lateral diffusion rate while it is bound to PIP2.  The most likely explanation for the five 
magnitude lower diffusion rate of PIP2 to other phospholipids is a direct link between 
PIP2 and the cytoskeleton.  It has been shown that PIP2 levels regulate membrane 
dynamics and cell shape by locally increasing and decreasing the interactions between 
the plasma membrane and actin cytoskeleton (Raucher, Stauffer et al. 2000).  The low 
diffusion rate of PIP2 could be the effect of myo1c or another protein linking the 
phosphatidyl inositol directly to the cytoskeleton.  If PIP2 is linked to the cytoskeleton 
through a protein tether, it would significantly inhibit its lateral diffusion, which would 
explain the large difference between lateral diffusion rates between PIP2 and other 
phospholipids. With the cytoskeleton being within 10.2 nm of the plasma membrane 
(Morone, Fujiwara et al. 2006), it is plausible that myo1c may function as a protein 
tether, especially given that a similar myosin-I, myo1a, has an estimated length of 22 
nm (Jontes and Milligan 1997).  However, PIP2 would not be able to anchor myo1c to 
the membrane if myo1c is the reason for the lateral diffusion rate of 3.9 x 10
-4
 µm
2
/s.  
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4.4.2 Force Perpendicular to the Membrane 
An alternative function of myo1c bound to the membrane is to deform the 
membrane by applying forces perpendicular to the membrane rather than in the plane of 
the membrane (Figure 51).  We estimate that these interactions will withstand forces 
greater than 40 pN because under similar conditions, the detachment forces of myelin 
basic protein from the membrane has been measured to be more than 40 pN (Mueller, 
Butt et al. 1999).  Myo1c could function in the deformation of the membrane to induce 
vesicle fusion or scission, as well as lamellipodia and neuronal growth cone retraction 
and expansion.  The force required to pull out a membrane tether in vitro was measured 
to reach ~50 pN and required the coordinated pulling of multiple motors (Leduc, 
Campas et al. 2004).  At these forces, it is feasible that an ensemble of myo1c motors 
bound to PIP2 on the membrane could pull out a membrane tether without being pulled 
off the membrane. 
It is not necessary for myo1c to actively produce force to function in processes 
that deform the membrane.  In both endocytic and exocytic events at the membrane, 
myo1c may act as a tether, connecting the growing barbed ends of actin filaments to 
sites of membrane deformation.  This has been proposed as the function of myo1c in 
compensatory endocytosis of fertilized Xenopus eggs (Sokac, Schietroma et al. 2006).  
Actin polymerization alone can produce forces of up to 1 pN (Footer, Kerssemakers et 
al. 2007).  Linking the growing ends of actin to the membrane at sites of endocytosis 
may induce stall forces on myo1c, keeping it bound to actin in an ADP bound state as 
the forming vesicle pulls the myo1c towards the pointed ends of an actin filament.  This 
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would allow actin filaments to be properly oriented to produce the forces on the plasma 
membrane required for vesicle formation.  
 
Figure 51 Forces perpendicular to the membrane 
  
  
Figure 51: Cartoon of myo1c producing force perpendicular to the 
membrane.  A) Myo1c bound to both actin and PIP2 pre-powerstroke.  
B) Myo1c after powerstroke deforms the membrane as it pulls up 
perpendicularly to the membrane. 
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4.4.3 Model for Myo1c Recruitment to the Membrane 
Myo1c diffusing in the membrane is under no load and acts as a low duty-ratio 
motor of 0.05 (Gillespie 2004).  Myosin-Is have been shown not to bind to actin that is 
saturated with tropomyosin like filaments found in stress fibers.  Thus, myo1c will 
diffuse until it reaches the dynamic actin network near the plasma membrane that is not 
coated with tropomyosin.  Near the plasma membrane, myo1c will bind to free PIP2 
through its tail domain and then further strengthen its avidity through interactions of its 
regulatory domain with anionic lipids.  PIP2 and tropomyosin-free actin created by 
phosphatidylinositol production or release from sequestering proteins, and the activation 
of new actin polymerization respectively, will create newly available binding sites for 
myo1c.  Myo1c will localize to these areas of high local concentrations of PIP2 on the 
membrane.  As myo1c bound to the membrane binds to actin and goes through its 
catalytic cycle, the motor will become strained, and its duty ratio will increase at stall 
forces (Figure 52).  Myo1c in this state will act as a tether, linking the actin 
cytoskeleton to the plasma membrane.   
An ensemble of myo1c motors in such a state has been hypothesized to maintain 
the tension on transduction channels in hair cells (Batters, Arthur et al. 2004).  When 
the channel opens and tension is released, the ensemble of motors climbs up the actin 
filaments in the stereocilia until the channel is closed and the tension is reset.  At the 
membrane, myo1c motors are held in an isometric contraction, linking the membrane to 
the underlying cytoskeleton; force from actin polymerization will act on the membrane 
as barbed ends are kept close to the membrane interface by myo1c (Figure 52).  These 
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forces have been proposed to be involved in such processes as membrane fusion, 
compensatory endocytosis, and neuronal growth cone turning (Bose, Guilherme et al. 
2002; Wang, Liu et al. 2003; Sokac, Schietroma et al. 2006).  If the strain on myo1c is 
below its stall force, myo1c will complete its powerstroke, resulting in the translocation 
of the actin filament.  This could be the result of a free actin filament, or many myo1c 
motors working together to produce a cooperative force.  Therefore, an ensemble of 
myo1c motors working cooperatively could produce forces necessary to deform the 
membrane or even pull out a lipid tubule (Figure 52).  In conclusion, myo1c has been 
determined be involved in many cellular processes at the membrane involving the actin 
cytoskeleton.  Although many of the functional details are still elusive, knowing that 
myo1c binds tightly to PIP2 is an important step to understanding the possible roles for 
myo1c. 
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Figure 52 Model of Myo1c functions at the plasma membrane 
  Figure 52: Cartoon of 3 possible functions of myo1c 
at the membrane involved in endocytosis, 
lamellipodial extention, and exocytosis. 
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4.5 Future Directions 
 We have characterized the mechanism by which myo1c binds to the plasma 
membrane.  Myo1c binds to the membrane through a direct interaction with the head 
group of PIP2, and through a secondary, electrostatic interaction via the regulatory 
domain.  There is still more work needed to be done to understand what role the 
myosin-I motors play as a link between the cytoskeleton and the plasma membrane.  A 
full length construct containing the motor and tail domains of myo1c is essential to 
properly answer this question, as is a crystal structure of the PIP2 binding region to 
better understand the specific binding site for PIP2. 
 
4.5.1 Myosin-I Isoform Phosphatidylinositol Binding Specificity 
 The characterization of the binding specificities of all of the myosin-I isoforms 
will lead to a greater understanding of their non-redundant localization and function in 
the cell.  All of the short-tail isoforms contain the PH domain signature motif and are 
therefore predicted to bind to phosphatidylinositols.  Long-tail isoforms have been 
shown to bind to the membrane, but do not contain the PH domain signature motif.  
Differences in non-conserved residues may lead to stereo-specificity of head group 
binding like that seen in PH domains.  This would lead to subcellular localization of 
different myosin-I isoforms to membranes enriched in specific phosphatidylinositols.  
Regulation of phosphatidylinositols through kinases and phosphatases would also 
regulate the localization and activity of the myosin-Is that bind to them.  Differentiating 
the specific phosphatidylinositol binding of the myosin-I isoforms as well as obtaining 
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crystal structures of their membrane binding sites will lead to a better understanding of 
their specific and non-redundant biological roles. 
 
4.5.2 Forces 
 Determining the forces that myo1c can apply to the membrane during a 
powerstroke will define the functions that it can perform while bound to the membrane.  
Binding forces and lateral diffusion coefficients are needed to define these functions, 
and knowing these will allow us to better postulate whether or not myo1c will be able to 
translocate an actin filament relative to the membrane or deform the membrane.  If 
myo1c cannot perform either of these functions, it is more likely that it acts as a tether 
or tension sensor rather than a motor while bound to the membrane.  Finally, a full 
length construct is required to determine the possibilities and limitations of a myosin-I 
acting as a motor while bound to the membrane. 
 
4.5.3 Regulation 
 How the interactions of myosin-Is with the membrane are regulated remains 
unknown.  Many lipid binding proteins are regulated by the lipids themselves.  
Phosphatidylinositol levels at the membrane are highly dynamic and are controlled by 
many signaling cascades in the cell.  However, this would require binding specifity of 
the different myosin-I isoforms.  Other modes of regulation involve other proteins 
binding to the lipid binding site. One possibility is a protein sterically blocking the lipid 
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binding site with binding of another protein to inhibit membrane localization.  Also, 
binding partners that are themselves membrane bound could enhance the association of 
a myosin-I with the membrane.  In the case of myo1c, cadherin 23 is a transmembrane 
protein that could form a complex with myo1c and the transduction apparatus in the 
stereocilia of hair cells.  Phosphorylation could also regulate the interactions of a 
myosin-I with the anionic membrane by neutralizing the basic charge of its binding site.  
Finally, one must consider Ca
2+
 regulation on the conformation and dissociation of one 
or more CaM from the regulatory domain.  We have shown that Ca
2+
 increases the 
affinity of the regulatory domain for anionic lipids in vitro.  Whether this increased 
affinity is physiologically relevant remains to be seen. 
 
4.5.4 Binding Partners 
 The tail domains of the different short-tailed myosin-Is is the proposed region 
responsible for membrane association.  However, this does not imply that their only 
function is to bind to lipids.  The tail domains of myosin are generally thought of as a 
cargo binding domain.  The tail domains of myosin-Is could have unique binding 
partners depending on the isoform.  This would explain why there are multiple isoforms 
expressed in the same cell and their differing functions.  Myo1c has been shown to bind 
to PHR1, NEMO, and cadherin 23; however, the function of each of these interactions 
is not clear.  Determining the binding partners for all of the myosin-I isoforms is an 
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important step to complete their characterization and uncover what their biological roles 
are at the membrane. 
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5 Abbreviations  
1. ADP adenosine diphosphate 
2. ATP adenosine triphosphate 
3. BSA, bovine serum albumin 
4. Ca2+, calcium ion 
5. CaM, calmodulin 
6. CHO, Chinese  hamster ovary 
7. COS-7, African green monkey cells 
8. DAG, diacylglycerol 
9. DEAE, Diethylaminoethyl 
10. DLS, dynamic light scattering 
11. DMEM, Dulbecco's Modification of Eagle's Medium 
12. DNTB, 5,5´-dithiobis-(2-nitrobenzoic acid) 
13. DTT, dithiothreitol 
14. ECL, enzymatic chemilumenscence 
15. ED, effector domain 
16. EDTA, ethylenediamine tetraacetic acid 
17. EF-hand, helix-turn-helix motif 
18. EGTA, ethylene glycol tetraacidic acid 
19. FBS, fetal bovine serum 
20. FL, fluorescein 
21. FLAG, polypeptide protein tag (N-DYKDDDDK-C) 
22. FPLC, fast performance liquid chromatography 
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23. FRAP, fluorescence recovery after photobleaching 
24. FRET, fluorescence resonance energy transfer 
25. GFP, green fluorescence protein 
26. GST, glutathione-S-transferase 
27. 3[H]Ins(1, 4,5)P3, tritiated Ins(1,4,5)P3 
28. HEK 293T, human embryonic kidney 
29. HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
30. HNa100, 10 mM HEPES, pH 7.0, 100 mM NaCl, 1 mM EGTA, 1 mM DTT 
31. IgG, immunoglobulin G 
32. Ins(1,2,3,5,6)P5, d-myo-inositol-1,2,3,5,6-pentakisphosphate 
33. Ins(1,2,5,6)P4, d-myo-inositol-1,2,5,6-tetrakisphosphate 
34. Ins(1,2,6)P3, d-myo-inositol-1,2,6-trisphosphate 
35. Ins(1,3,4)P3, d-myo-inositol-1,3,4-trisphosphate 
36. Ins(1,3,4,5)P4, d-myo-inositol-1,3,4,5-tetrakisphosphate 
37. Ins(1,3,4,6)P4, d-myo-inositol-1,3,4,6-tetrakisphosphate 
38. Ins(1,4,5)P3, d-myoinositol-1,4,5-trisphosphate 
39. Ins(3)P1, d-myo-inositol-3-monophosphate 
40. InsP6, d-myo-inositol hexakisphosphate 
41. IPTG, isopropyl β-D-1-thiogalactopyranoside 
42. K+, potassium ion 
43. LUV, large unilamellar vesicle 
44. MARCKS, myristoylated alanine rich C kinase substrate 
45. MES, 2-(N-morpholino)ethanesulfonic acid 
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46. Mg2+, magnesium ion 
47. N2, nitrogen 
48. NEMO, nuclear factor κB essential modulator 
49. NRK, normal rat kidney 
50. N-WASP, Neural Wiskott-Aldrich syndrome protein 
51. OD, optical density 
52. PA, phospatidic acid 
53. PBS, phosphate buffered solution 
54. PC, phosphatidylcholine 
55. PDB, protein data bank 
56. PDK1, 3-phosphatidylinositol-dependent protein kinase 1 
57. PE, phosphatidyl ethanolamine 
58. PG, phosphatidylglycine 
59. PH, pleckstrin homology 
60. PI, phospophoinositol 
61. PI3K, phosphoinositol-3 kinase 
62. PIP2, phosphatidyl inositol-4,5-bisphosphate 
63. PKC, protein kinase C 
64. PLC, phospholipase C 
65. PMSF, phenylmethylsulphonyl fluoride 
66. PPB poly-phosphatidylinositol binding 
67. PPD, p-phenylenediamine 
68. PS, phosphatidylserine 
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69. RPMI, Roswell Park Memorial Institute medium 
70. SDS-PAGE, sodium dodecyl sulfate polyacylamide gel electrophoresis 3H-
Ins(1,4,5,)P3, Tritium labeled Ins(1,4,5,)P3 
71. SH3,src homology 3 
72. SI, soybean inhibitor 
73. TIRF, total internal reflection fluorescence 
74. TMR, tetramethylrhodamine 
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